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Hydrogen sulphide (H2S) has been positioned as the third candidate of 
gasotransmitters following after nitric oxide (NO) and carbon monoxide (CO). As a 
biological gas which is endogenously generated by cystathionine β-synthase (CBS) and 
cystathionine γ-lyase (CSE), H2S was shown to exert various physiological functions in 
the mammalian system. Despite the vast number of reports on the physiological role of 
H2S, studies on the signaling mechanisms of H2S remain an undiscovered area. Majority 
of the studies have suggested a central role for the activation of KATP channels and the 
MAP Kinase, ERK. With its readily diffusible property, H2S should possess a wild range 
of signaling mechanisms such as those in NO and CO. The current study attempts to 
discover other possible signaling mechanisms of H2S.  
In the current study, the role of H2S in calcium homeostasis of primary cultured 
microglia, a member of the glial population in the central nervous system was examined 
using calcium imaging with Fura-2/AM fluorescent dye. Microglia was shown to express 
CSE but not CBS. Exogenous H2S (100 – 500 µM) increased intracellular calcium 
concentration ([Ca2+]i) via calcium influx and calcium release from intracellular stores. 
More importantly, inhibition of endogenous H2S synthesis with 2 mM PAG or 2 mM 
BCA, two inhibitors of CSE, suppress the basal level of [Ca2+]i. As such, H2S was shown 
to play a role in the calcium homeostasis of microglia, which may have an impact on the 
activation status of microglia.  
In the cardiovascular system, the effect of H2S on intracellular pH (pHi) of 
smooth muscle cell line, A7r5 cells, was examined using BCECF/AM, a pHi sensitive 
 x 
dye. Exogenous H2S (10 µM – 1 mM) was shown to decrease pHi via activation of Cl-
/HCO3- exchanger. Moreover, the acidosis induced by H2S was shown to be partly 
responsible for the vasodilatory effect of H2S.  
Lastly, the effect of endogenous H2S in a cardioprotective model characterized by 
activation of pro-survival kinase, ischemic postconditioning (IPostC), was examined 
using isolated rat heart model. Isolated perfused hearts were subjected to ischemia- 
reperfusion and their contractile functions were assessed. Inhibition of H2S diminished 
the protective effect of IPostC maneuver along with attenuation of PKCε translocation. 
100 µM H2S was shown to activate Akt and PKC when given either in intermittent six 
10s cycles or continuously for two minutes to produce pharmacological postconditioning. 
Different H2S protocol has a different activation profile of Akt and PKCε although the 
protective effect was similar when assessed by contractile functional measurements. 
Inhibition of either kinase diminished/reversed the protective effect of H2S 
postconditioning. As such, endogenous H2S may play a role in mediating PKCε 
activation triggered by ischemic postconditioning whereas H2S postconditioning confers 
protective effect against ischemia-reperfusion injury via activation of Akt and PKCε.  
 To conclude, the present study has unveiled three potential signaling mechanisms 
for H2S, namely regulation on [Ca2+]i in the nervous system, regulation on pHi in vascular 
smooth muscle cells and activation of Akt and PKC in the heart. These signaling 
pathways may be exploited to further understand the diverse physiological functions of 
H2S yet to be identified. 
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1.1.1 Definition of gasotransmitters 
Up to date, most of the signaling mechanisms unveiled in various cell types are 
usually initiated via binding of a signaling molecule to another target protein such as the 
receptors, enzymes or ion channels, which represents a form of ligand-receptor binding. 
However, ever since the discovery of nitric oxide (NO), an additional mode of signal 
initiation and transduction has been introduced. As a lipophilic gas, NO is able to 
penetrate the membrane and elicits receptor-independent signaling mechanisms, which 
represents a revolutionary mode of signaling mechanism. Followed after NO, carbon 
monoxide (CO) and hydrogen sulphide (H2S) are shown to trigger similar receptor-
independent signaling mechanism. As such, Wang R. introduced the term, 
gasotransmitter, to distinguish these gaseous transmitters from traditional receptor 
dependent neurotransmitters and humoral factors (Wang R, 2002). Accordingly, several 
criteria have been proposed to differentiate these gaseous molecules: 
1. they are small molecules of gas; 
2. they are freely permeable to membrane; 
3. they are endogenously and enzymatically generated; 
4. they have well-defined physiological functions at physiological levels; and 
5. they have specific targets. 
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Up to date, three gases have been identified to qualify the above criteria, namely NO, CO 
and the main focus of this thesis, which is the third member of gasotransmitter, H2S. 
 
 
1.2 The third member: hydrogen sulphide 
 
1.2.1 Physical and chemical properties of H2S 
Hydrogen sulphide (H2S) is a naturally occurring gas in the environment and the gut. It is 
colorless and has a strong characterizing rotten egg smell. It is a small molecule with a 
molecular weight of 34.08. With a pKa of 7.04, H2S is weakly acidic, dissociating in 
aqueous solution into hydrogen ions H+ and the hydrosulfide anion HS−: 
H2S → HS− + H+  
However, one third of H2S remains as undissociated form in an aqueous solution of pH 
7.4 at 25 ºC (Wang, 2002). H2S is lipophilic and thus readily permeable and diffusive in 
the plasma membranes.  
 
1.2.2 Past view: H2S as a toxic gas 
Traditionally, H2S has been viewed as a toxic gas which is comparable with 
hydrogen cyanide. It is, in fact, more toxic than hydrogen cyanide and CO, where fatality 
can occur at an exposure as little as 300 ppm in air for 30 minutes (Pryor, et al., 2006). 
Many reports of fatal intoxication have been profiled (Smith and Gosselin, 1979; Milby, 
1962; Burnett et al., 1977; Zhang et al., 2006) with majority of the incidents occurring in 
occurred in chemical industry, mining, water disposal industry, paper making industry 
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and brewing industry. When exposed at high concentration, acute intoxication results in 
several clinical signs including apnea (loss of central respiratory drive from brainstem 
neurons), hypoxic convulsions, and death (Warenycia et al., 1988). At molecular level, 
the main toxicity of H2S has been attributed by its potent inhibition on cytochrome c 
oxidase, which is the terminal enzyme of oxidative phosphorylation (Dorman et al., 
2002). In addition, H2S was shown to induce cell death in isolated hepatocytes via 
formation of reactive oxygen species and mitochondrial depolarization (Eghbal et al., 
2004).    
 
1.2.3 Current view: H2S as a gasotransmitter  
 Recently, H2S has been positioned as the third member of gasotransmitter based 
on three lines of evidence: 
1. a considerable amount of H2S has been detected in the blood plasma of 
mice, rats and human, e.g. ≈ 46 µM H2S in rat serum , and 50-160 µM H2S 
in brain homogenates; 
2. the identification of several H2S synthesizing enzymes, e.g. cystathionine 
β-synthase (CBS) and cystathionine γ-lyase (CSE); 
3. the physiological roles of H2S demonstrated in different systems recently, 
e.g. modulation of long-term potentiation,  regulation of vascular tones etc. 
As such, H2S has been proposed to serve as a neuromodulator in the nervous system, a 





1.2.4 Endogenous synthesis of H2S 
H2S is generated endogenously in the mammalian cells mainly by enzymatic and 
to a lesser extend by non-enzymatic ways. Three enzymes have been identified to be 
responsible for production of endogenous H2S mainly via desulphuration of cyst(e)ine 
from cystathionine-β-synthase (CBS, EC 4.2.1.22) and cystathionine-γ-lyase (CSE, EC 
4.4.1.1) in the cytosol; and to a lesser extent by 3-mercaptopyruvate sulphurtransferase 
(MST; EC 2.8.1.2) in mitochondria (Kamoun, 2004). These enzymes have a different 
expression profile in different tissues, giving rise to a wide range of H2S concentration in 
the respective organs. Thus, the respective amount of H2S produced may vary depending 
on the species and organs considered.  
Both CBS and CSE are pyroxidal 5’-phosphate (PLP) dependent enzymes. They 
are two of the main players in the metabolism of L-cysteine (Kamoun, 2004) and thus the 
generation of H2S from its main substrate, L-cysteine (Fig. 1). CSE catalyzes a β-
disulphide elimination reaction that results in the production of pyruvate, NH4+ and 
thiocysteine. Thiocysteine may react with cysteine or other thiols (Stipanuk and Beck, 
1982; Yamashi and Tuboi, 1981) or decomposes non-enzymatically (Cavallini et al., 
1962) to form H2S. Alternatively, CSE may directly hydrolyze cysteine to generate 
pyruvate, NH4+ and H2S. In contrast to CSE, CBS serves to substitute the thiol group of 




















Fig. 1. Endogenous enzymatic production of H2S in mammalian cells. Endogenous H2S 
was mainly synthesized by CBS (E.C. 4.2.1.22) and CSE (E.C. EC 4.4.1.1) from L-
cysteine, which is the main substrate. L-cysteine was mainly generated by metabolism of 
homocysteine.   
 
 CBS is mainly detected in the brain, liver, kidney and ileum. Using northern blot 
analysis, CBS was shown to be highly expressed in the hippocampus and cerebellum 
compared with the cerebral cortex and brain stem whereas no CSE was detected (Abe and 
Kimura, 1996). More importantly, CBS activity was detected in a variety of tissues 
including liver, kidney, brain, small intestine, pancreas, adipose but not the heart 
(Finkelstein, 1990; Kamoun, 2004). In addition, incubation of brain homogenates with 
aminooxyacetate (AOAA), a potent inhibitor of CBS (IC50 = 10-4 M) (Braunstein et al., 
1971), decreased the concentration of H2S in brain homogenates (Abe and Kimura, 1996) 
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and ileum (Hosoki et al., 1997) concentration-dependently, further confirming the role of 
CBS in these tissues. 
 In contrast to CBS which is mainly expressed in the brain, CSE is the enzyme 
mainly expressed and responsible for the production of H2S in the cardiovascular system. 
CSE mRNA transcripts have been detected in the pulmonary artery, tail artery, 
mesenteric artery, aorta, endothelium-free vascular smooth muscle, liver (Zhao et al., 
2001), kidney (Li et al., 2005), pancreas (Bhatia et al., 2005)  and heart (Geng et al., 
2004b). Similarly, incubation of the tissues with D, L-propargylglycine (PAG) (IC50 = 10-4 
M) (Uren et al., 1978; Stipanuk and Beck, 1982), an irreversible inhibitor of CSE 
significantly diminished the H2S production activity in liver (Mok et al., 2004, Li et al., 
2005) kidney (Li et al., 2005) and pancreas (Bhatia et al., 2005). Besides PAG, β-cyano-
L-alanine (BCA) is the other candidate of CSE inhibitor. BCA inhibits CSE in a 
competitive manner (IC50 = 10-5 M) (Rfeffer and Ressler 1967; Uren et al., 1978). 
however, its use was not as widely accepted as PAG.  
 
1.2.5 Endogenous level of H2S 
Local concentrations of endogenous H2S have been an area of interests since 1986. 
Due to the different expression profiles of CBS and CSE in different tissues, the 
concentration of H2S varies greatly. Table 1 summarized the plasma concentration of H2S 
measured in different species whereas Table 2 summarized the relative activities of H2S-








































































































































































































































































































































































































































































1.2.6 Metabolism of endogenous H2S 
Endogenous H2S is metabolized via three major routes: (1) oxidation in 
mitochondria; (2) methylation in cytosol and (3) scavenging by methemoglobin or 
metallo- or disulfide-containing molecules such as oxidized glutathione (Wang, 2002).  
With its diffusible property in biological membranes, H2S is readily metabolized 
in mitochondria initially to thiosulphate which is further converted to sulphite and sulfate. 
The sulphites are rapidly oxidized to sulphate by sulphate oxidase in mitochondria. 
Eventually, the end-products, sulphates, are excreted by the kidney in either free or 
conjugated form (Beauchamp et al., 1984; Lowicka and Beltowski, 2007).  
Besides, H2S is also methylated in the cytosol by thiol S-methyltransferase 
(TSMT) to methanethiol and dimethylsulfide (Furne et al., 2001). Last but not least, H2S 
could be scavenged by methemoglobin to form sulfhemoglobin (Lowicka and Beltowski, 
2007), positioning hemoglobin as the common sink for the three gasotransmitters (Wang, 
2002).    
 
 
1.3 Overview on physiological functions of H2S 
 
1.3.1 Physiological functions of H2S in the nervous system 
The first physiological effect of H2S was demonstrated in 1996 by Abe and 
Kimura. In this study, H2S was shown to increase the sensitivity of Long Term 
Potentiation (LTP) via enhancing the response of N-methyl-D-aspartic acid (NMDA) 
receptor (Abe and Kimura, 1996). Physiologically, the mechanism by which H2S 
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enhances NMDA receptor-mediated response has been linked to cyclic-AMP (cAMP) 
production where exogenous H2S increases the production of cAMP in primary cultures 
of rat cerebral and cerebellar neurons, or in selected neuronal cell line and glial cell lines 
(Kimura, 2000).  
Recently, it has also been shown that H2S up-regulates gamma-aminobutyric acid 
(GABA) B receptor (GABABR), a G protein-coupled receptor located at pre- and post-
synaptic sites (Han et al., 2005). Stimulation of the post-synaptic receptors generates 
long-lasting inhibitory post-synaptic potentials, which result in the increase of K+ 
conductance and are important for the fine-tuning of inhibitory neurotransmission. At 
pre-synaptic sites, GABABR mediates the release of neurotransmitters, such as GABA 
and glutamate, by inhibiting the voltage-sensitive Ca2+ channels. The up-regulated 
GABABR expression by H2S implies that H2S may play a part in maintaining the 
excitation/inhibition balance in brain. 
 In addition to its neuromodulatory role, H2S has been shown to protect the 
neurons from oxidative stress in both extracellular and intracellular microenvironment. 
Thiol-reduced form of glutathione (GSH) is an important antioxidant defense in the brain. 
Interestingly, H2S shares several similar neuroprotective mechanisms with GSH with a 
compatible potency in vitro by: (i) inhibiting hypochlorous acid-mediated oxidative 
damage (Whiteman et al., 2005); and (ii) inhibiting peroxynitrite-mediated protein 
nitration and cytotoxicity (Whiteman et al., 2004). In addition, H2S scavenges hydrogen 
peroxide (H2O2), an important source of oxidative stress in most cells, very readily in 
vitro (Geng et al., 2004a). Although intracellular GSH levels in neurons and glia are in 
millimolar concentration, extracellular levels of GSH in the brain is almost zero in 
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extracellular microenvironment of the brain (Halliwell, 2001; Bayir et al., 2002; 
Whiteman et al., 2005). Thus, the extracellular environment has a high dependency on 
other homeostatically regulated non-glutathione antioxidants such as ascorbate to 
scavenge free-radicals (Rice, 2000). As such, H2S may serve as another important 
candidate of endogenous antioxidant in the brain extracellular microenvironment due to 
its high endogenous production, readily diffusible property and comparable antioxidant 
potency with GSH.  
Besides the antioxidant role mimicking GSH in extracellular microenvironment, 
H2S protects the neurons by increasing the anti-oxidative glutathione production (Kimura 
and Kimura, 2004). NaHS treatment alone is able to increase the amount of GSH by 
enhancing the activity of γ-glutamylcysteine synthetase (γ-GC) and up-regulating cystine 
(rate-limiting substrate of glutathione synthesis) transport. This protection increases the 
cell viability of H2S pre-treated neurons to an extent comparable with those without 
glutamate challenge (Kimura and Kimura, 2004). In addition, H2S protect an 
immortalized mouse hippocampal cell line from oxidative glutamate toxicity by 
activating ATP-sensitive potassium (KATP) and Cl- channels, in addition to increasing the 





























Fig. 2. Summarized physiological functions of H2S in neurons. γ-GCS, γ-
glutamylcysteine synthase; LTP, long-term potentiation; PKA, cAMP-dependent protein 
kinase A; ROS, reactive oxygen species. 
  
1.3.2 Physiological functions of H2S in the cardiovascular system 
In the cardiovascular system, H2S was shown to cause vasorelaxation through 
activating KATP channel (Zhao et al., 2001), which form the basis for various follow-up 
studies on H2S. Zhao et al. have shown that application of NaHS or H2S solution causes 
vasodilation in a concentration-dependent manner. This effect was observed at 
concentrations higher than 60 µM NaHS. The vasodilatory effect was not only observed 
in thoracic aorta, but also in mesenteric arteries (Cheng et al., 2004), ileum (Teague et al., 
2002) and portal vein (Hosoki et al., 1997).  More importantly, H2S was shown to 
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regulate vascular tone where a bolus injection of exogenous H2S decreased blood 
pressure in anesthetized rats (Zhao et al., 2001; Ali et al., 2006).  
In the heart, continuous administration of H2S decreased myocardial contractility 
(Geng et al., 2004b). However, H2S was generally being viewed as a cardioprotective 
agent. Various studies up to date have demonstrated that H2S could protect the heart from 
myocardial injury in different set ups ex vivo and in vivo (Johansen et al., 2006; Zhu et al., 
2007; Sivarajah et al., 2006). Pre-administration of H2S was shown to reduce ischemia-
reperfusion injury when assessed with infarction size, the gold standard to assess 
myocardial damage. More importantly, H2S preconditioning (SP produced cardiac 
protective effects similar to that induced by ischemic preconditioning, a potent 
cardioprotective event (Pan et al., 2006; Bian et al., 2006). Although the exact 
mechanism has yet to be identified, it is generally accepted that H2S possesses a 
cardioprotective role in the heart especially upon ischemia challenge. 
 
1.3.3 Physiological functions of H2S in inflammation 
The vasodilatory effect of H2S which is parallel to that of NO suggested a pro-
inflammatory role for H2S. Indeed, various inflammation models have suggested a rise in 
H2S formation during inflammation. Interestingly, inhibition of H2S synthesis blunted the 
inflammatory responses. In a mice (Li et al., 2005) and rat septic shock (Collin et al., 
2005) model, inhibition of H2S synthesis with PAG significantly decreased the 
inflammation when assessed by different inflammatory indices such as lung and liver 
myeloperoxidase (MPO) activity, tissue structure, and plasma concentration of the 
cytokine tumour necrosis factor-α (TNF-α) to rule-out the role of pro-inflammatory 
 13 
vasodilatory effect of H2S. In a carrageenan-induced hind paw edema rat model, pre-
treating the rats with PAG significantly reduced the edema due to carrageenan injection. 
This anti-inflammatory effect of H2S was also observed in a pancreatitis model where 
PAG, either given as a prophylactic or therapeutic significantly reduced the severity of 
caerulein-induced pancreatitis and associated lung injury. In addition, in a cecal ligation 
and puncture-induced sepsis mice model, H2S was shown to act as an inflammatory 
mediator by up-regulating the production of cytokines and chemokines via Nuclear factor 
κB (NF-κB) (Zhang et al., 2007). Taken together, H2S not only contributes to 
hypotension but also augments the inflammatory response and end-organ damage 
associated with sepsis. At cellular level, H2S induces the synthesis of pro-inflammatory 
cytokines in human monocyte cell line via the extracellular signal-regulated protein 
kinases (ERK) in ERK-NF-κB pathway (Zhi et al., 2007). 
 Interestingly, various studies at cellular level have suggested an opposite anti-
inflammatory role for H2S. Renata et al., have reported that H2S inhibited aspirin-induced 
leukocyte adherence in mesenteric venules via activation of KATP channels. In addition, 
inhibition of endogenous H2S synthesis elicited leukocyte adherence, suggesting an anti-
inflammatory role for H2S, at least in terms of leukocyte infiltration (Renata et al., 2006). 
In cultured murine RAW264.7 macrophages, H2S solution suppressed the 
lipopolysaccharide (LPS)-induced expression of inducible NO synthase (iNOS), which is 
responsible for the production of pro-inflammatory NO. Besides, activation of ERK, 
increased CO production and CO-mediated inhibition of pro-inflammatory NF-κB was 
also noted (Oh et al., 2005). In another neuroinflammation model, H2S was shown to 
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inhibit LPS-induced NO and TNF-α release in primary cultured microglia and astrocytes 
in a p38 mitogen-activated protein kinase (MAPK) dependent manner (Hu et al., 2007). 
 Although discrepancies still exist on whether H2S is pro- or anti-inflammatory, 
the common thread is that H2S acts a double-edged sword by serving as a mediator in 
inflammation.  
 
1.3.4 Physiological functions of H2S in other systems 
Besides the above mentioned major physiological functions, various roles of H2S 
in different systems were beginning to be unveiled. Over-expression of CSE as well as 
exogenous H2S inhibit glucose-induced insulin release, which is associated with the 
direct stimulation of KATP channels independent of cytosolic second messengers. In 
contrast, lowering of endogenous H2S by PAG or CSE-targeted short interfering mRNA 
has the opposite effect. These data suggest that endogenous H2S inhibits insulin secretion 
(Yang et al., 2005).  
In the gastrointestinal system, endogenous H2S played a role in the maintenance 
of portal venous pressure. H2S attenuates the norepinephrine-induced vasoconstriction in 
the liver of healthy rat as well as in animals with experimental liver cirrhosis induced by 
bile duct ligation. Besides, reduction of CSE expression in the liver with cirrhosis was 
shown to contribute to the development of increased intrahepatic resistance and portal 







1.4 H2S in pathological state 
 
1.4.1 Abnormal metabolism of H2S 
 Up to date, only a handful of studies have been focusing on the abnormal 
metabolism of H2S which is genetically linked. In fact, most of the studies are focused on 
the mutated expression of CBS, and its impact on homocysteine metabolism rather than 
its by-product, H2S. Complete understanding on the role of H2S in the pathogenesis of 
these diseases remains largely unanswered. 
 Hyperhomocystinemia is a disease with a deficient expression of CBS. Patients 
with hyperhomocystinemia are usually suffered from premature peripheral and cerebral 
occlusive arterial diseases which could lead to diseases such as atherosclerosis and 
thrombotic complications (Boers et al., 1985). In addition, heterozygosity for 
homocystinuria predisposes the patients to the development of premature occlusive 
arterial disease, causing intermittent claudication, renovascular hypertension, and 
ischemic cerebrovascular disease. The pathogenic role of low levels of H2S in this disease 
has not been explored. Similarly, homocystinuria is an autosomal recessively inherited 
disorder that may be closely linked to the low endogenous production of H2S due to CBS 
deficiency (Wang, 2002).  
 Down syndrome is a genetic disorder caused by the presence of all or part of an 
extra 21st chromosome. Coincidentally, CBS is encoded by a gene on chromosome 21 
(21q22-3). As such, Down syndrome patients usually have an elevated expression of CBS. 
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The in vivo increase in CBS activity induces a decrease in the amount of CBS substrate 
(homocysteine) in the plasma of Down syndrome patients (Chadefaux et al., 1985). 
Down syndrome patients suffer from progressive mental retardation and it was 
hypothesized that abnormal accumulation of H2S in the brain could have caused the 
metabolic intoxication, which is compatible to that observed in phenylketonuria patients 
(Kamoun, 2001). Nevertheless, the role of H2S overproduction in mental retardation 
remains to be established.  
 
1.4.2 Change in H2S level during disease state 
 On the other hand, a change in H2S level has been reported in various disease 
states. In a stroke model created by permanent occlusion of the middle cerebral artery 
(MCAO), an increase in H2S level at the lesioned cortex as well as an increase in the H2S 
synthesizing activity was observed. In addition, administration of CBS or CSE inhibitors 
reduced the MCAO-induced infarct volume dose-dependently, further suggesting a 
detrimental role for H2S during cerebral ischemia (Qu et al., 2006). 
In the cardiovascular system, several studies have suggested a correlation between 
CSE activity, H2S concentration and myocardial injury. In human patients, it was 
reported that plasma H2S concentration was significantly lower in patients with coronary 
heart disease (Jiang et al., 2005). Besides, the concentration of endogenous H2S in 
plasma and myocardial tissue was significantly decreased in isoproterenol-induced 
myocardial injury (Geng et al., 2004a). In addition, the concentration of H2S detected in 
the medium of freshly isolated cardiac myocytes was decreased upon ischemia treatment 
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(Bian et al., 2006). Taken together, the common accepted trend is that the ischemia insult 
could induce a significant change in the production of endogenous H2S by CSE. 
 Besides, elevated tissue H2S formation was first reported in cecal ligation and 
puncture model and endotoxic shock model induced by injection of endotoxin in rats 
(Hui et al., 2003). Followed after this, elevation of H2S concentration in blood plasma has 
been reported in various inflammatory models. Plasma H2S concentration was 
significantly increased in a LPS-injection septic shock mice model (Li et al., 2005) and 
endotoxemia rat model (Collin et al., 2005). More importantly, plasma H2S 
concentrations of septic shock patients were also increased by 3.4 fold (Li et al., 2005).  
 Moreover, plasma H2S concentration is increased by almost 50% in patients with 
stable chronic obstructive bronchopulmonary disease (COPD) in comparison to the 
control group (Chen et al., 2005). In addition, an increase in H2S formation in the liver 




1.5 Signaling Mechanisms of H2S 
 
1.5.1 Stimulation of KATP channels 
ATP-sensitive potassium channel (KATP channel) is a kind of inward rectifying 
channel composed of two kinds of subunits: the pore forming subunits, inwardly 
rectifying potassium channel subunits (KIR6.1 or KIR6.2), and the larger regulatory 
subunits, sulphonylurea receptor (SUR). KATP channels exist in the sarcolemmal, 
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mitochondrial and nuclear membranes of various tissues (Zhuo et al., 2005). A hallmark 
and defining feature of KATP channels is their inhibition by micromolar concentrations of 
intracellular ATP (Babenko et al., 1996) i.e., an increase in intracellular ATP closes KATP 
channels which eventually leads to depolarization. Cell metabolism products regulate the 
channel by direct interactions, while KATP channels control the membrane potentials and 
regulate cell activities including energy metabolism, apoptosis and gene expression.  
KATP channels are found in many excitable cells including neurons, skeletal and 
smooth muscle, cardiac myocytes and hormone-secreting cells (Seino, 1999). In the brain, 
the brain, KATP channels are expressed most abundantly in the hypothalamus, which is 
critically involved in the regulation of energy metabolism (Levin et al., 1999). KATP 
channels in the hypothalamus are required for glucose sensing which is critical for 
glucagon secretion and alterations in feeding behavior during hypoglycemia (Miki and 
Seino, 2005). Besides hypothalamus, KATP channels are also highly expressed in 
substantia nigra pars reticulata which plays a pivotal role in suppressing the propagation 
of generalized seizures. During seizure, the cerebral metabolic rate of oxygen increases 
more than under any other circumstance, leading ultimately to irreversible cell damage. 
The nigral neuron activity was rapidly inactivated during hypoxia by the opening of the 
post-synaptic KATP channels to minimize the excessive energy consumption which could 
lead to seizure-induced damages, thus suggesting a neuroprotective role for KATP 
channels during seizure. 
In smooth muscle cells, KATP channels play a significant role in the vasodilatory 
responses to endogenous substances, such as adenosine, neuropeptides and endothelial 
factors. Pharmacological vasodilators such as cromakalim, pinacidil and diazoxide 
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directly activate KATP channels. The associated membrane hyperpolarization closes 
voltage-dependent Ca2+ channels, which leads to a reduction in intracellular Ca2+ 
concentration ([Ca2+]i) and vasodilation. In contrast, endogenous vasodilators such as 
calcitonin gene-related peptide, vasoactive intestinal polypeptide, prostacylin and 
adenosine activate KATP channels by stimulating the formation of cAMP and increasing 
the activity of protein kinase A (PKA). In addition, part of the mechanism of contraction 
of endogenous vasoconstrictors such as angiotensin II and serotonin is due to inhibition 
of KATP channels (Brayden, 2002). 
In cardiac myocytes, a decrease in the ATP level during ischemia or hypoxia 
produces membrane hyperpolarizing force through the activation of the KATP channels. 
The resultant shortening of the action potential duration diminishes membrane 
excitability and delays initiation of a cascade of cytotoxic events (Gross, 1997; Yamada 
and Inagaki, 2005). This poses KATP channel as the central mediator in two of the most 
potent cardioprotective phenomena, ischemic preconditioning (IP) (Gross and Fryer, 
1999) and ischemic postconditioning (IPostC) (Yang et al., 2004).   
In contrast, in pancreatic β-cells, closure of the KATP channels triggers a sequence 
of events leading to insulin secretion. Metabolism of glucose generates various metabolic 
signals including ATP. A rise in intracellular ATP concentration closes KATP channels 
which eventually lead to a depolarization and thus the opening of voltage-dependent Ca2+ 
channels. The resultant increase in [Ca2+]i triggers insulin secretion (Miki and Seino, 
2005). 
H2S was shown to open KATP channels directly in vascular smooth muscle cells 
(Zhao et al., 2001; Tang et al., 2005) and insulin secreting cells (Yang et al., 2005). More 
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importantly, various physiological effects of H2S demonstrated up to date was dependent 
on KATP activation. The vasodilatory effect of H2S and its regulation on vascular tone was 
shown to be dependent on activation of KATP channels (Zhao et al., 2001). Besides, H2S 
decreased myocardial contractility via the opening of KATP channels (Geng et al., 2004b). 
In addition, part of the protective effect of H2S against cellular injuries in cardiac 
myocytes (Bian et al., 2006; Sivarajah et al., 2006) and neuronal cell line (Kimura et al., 
2006) was at least dependent on the opening of KATP channels. On the other hand, the 
antinociceptive effect of H2S in the gastrointestinal tract especially in colorectal 
distension model (a model that mimics some features of the irritable bowel syndrome) 
was also mediated by KATP channels (Distrutti et al., 2005). 
 
1.5.2 Stimulation of MAP Kinases 
The MAPK cascade is a signaling system that transmits stimuli from outside the 
cell to the nucleus. MAPKs play important roles in a variety of cell processes by 
controlling transcriptional or translational regulation (Kyriakis and Avruch, 2001). Three 
major MAPK cascades have been well characterized in mammals, namely the ERK, c-
Jun N-terminal kinases (JNKs), and p38 MAPKs. Among the three MAPKs, ERKs are 
activated by various cytokines and growth factors and play a central role in cell growth 
and differentiation. On the other hand, JNKs and p38 MAPK are preferentially activated 
by chemical and physical stressors such as UV radiation, X-ray, heat shock and osmotic 
shock, and by proinflammatory cytokines such as TNF-α, and these cascades control 
stress adaptation, cell death and survival (Matsukawa et al., 2004). 
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Various studies have suggested a role for ERK1/2 as one of the downstream target 
for H2S. In HEK293 cells, over-expression of CSE which led to an increased production 
of endogenous H2S inhibited cell proliferation and DNA synthesis (Yang et al., 20004a). 
These effects were accompanied by a sustained ERK activation and an up-regulation of 
the cyclin-dependent kinase inhibitor p21Cip/WAK-1. On the other hand, application of 
exogenous H2S or induction of endogenous H2S synthesis via over-expression of CSE 
induced apoptosis in human aorta smooth muscle cells via activation of ERK (Yang et al., 
2004b; Yang et al., 2006).  
In inflammatory cells, the effect of H2S on stimulation of ERK was prominent. In 
RAW264.7 macrophages, H2S dose-dependently induced heme oxygenase (HO-1) 
expression through the activation of the ERK (Oh et al., 2006). Besides, in human 
monocytes, H2S stimulated the activation of monocytes with the generation of pro-
inflammatory cytokines, at least partially, through the ERK-NF-κB signaling pathway 
(Zhi et al., 2007). Although a study on microglia has suggested a role for p38 MAP 
kinase on its anti-inflammatory role (Hu et al., 2007), others have negated its role. This 
may be due to the pro- and anti-inflammatory role of H2S in different cell types and 
experimental set ups.  
 
1.5.4 Other signaling mechanisms of H2S 
Besides activating KATP channels and MAPK, H2S was also shown to activate 
various intracellular signaling mechanisms. H2S was shown to activate adenylyl cyclase 
in neurons, which would eventually lead to an increase in cAMP (Kimura, 2000). In 
addition, H2S was shown to react with various ROS and reactive nitrogen species (RNS) 
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(Geng et al., 2004a; Ali et al., 2006; Whiteman et al., 2004; Whiteman et al., 2005; 
Whiteman et al., 2006), which could possibly have an impact on the redox state of the 
cells. Besides, H2S was shown to trigger Ca2+ waves in astrocytes (Nagai et al., 2004).  
Taken together, H2S should possess a wild range of signaling mechanisms just like NO 




1.6 Clinical significance of H2S 
 
1.6.1 H2S as an additional drug moiety 
H2S released from NaHS was assumed to be transient, which mimics a bolus 
injection in the body with a high clearance rate. As such, systemic effect of H2S bolus 
injection might not sustained for a long period. Continuous and persistent prolonged 
release of H2S is desirable in clinical terms.  
Nitric oxide-releasing non-steroidal anti-inflammatory drugs (NSAIDs) (i.e., NO-
NSAID) such as nitroaspirin and nitronaproxen were first introduced in 1994 for the slow 
release of NO from the parent drug. NO-NSAIDs exhibit improved efficacy in a range of 
animal models of inflammation compared to their parent NSAID. Moreover, NO-NSAID 
has markedly reduced gastrointestinal toxicity. Both such actions are attributed by the 
slow release of NO from NO-NSAIDs, which thereafter provides an additional anti-
inflammatory effect (Keeble and Moore, 2002). 
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Similarly, H2S-releasing NSAIDs have been developed to evaluate additional 
approaches to the development of novel anti-inflammatory agents. Up to date, two studies 
have attached H2S as an additional moiety onto traditional drugs. Li et al. (2007) has 
demonstrated that S-diclofenac potentiated the anti-inflammatory effect of diclofenac in 
LPS-induced septic shock rat model with significantly less gastric toxicity. S-diclofenac 
has a H2S-releasing dithiol-thione moiety attached by an ester linkage to diclofenac (Fig. 
3). This poses an interesting view on the exact role of H2S, with transient increase in H2S 
having a pro-inflammatory role and prolonged continuous release of H2S having an anti-
inflammatory role (Li et al., 2007). In another study, the similar drug with a different 
nomenclature (HS-NSAID) markedly suppressed the prostaglandin synthesis in a 
carrageenan-induced paw edema model with lesser intestinal damage and had no effect 















1.7 Hypotheses and Objectives 
Despite the vast number of studies on H2S being reported, tremendous efforts 
have been contributed to unveil its physiological roles in different biological systems. 
However, in the attempt to discover the downstream signaling mechanism of H2S, most 
of the studies have pointed to KATP channels and ERK as the major downstream target of 
H2S. As a gaseous molecule, H2S possesses the ability to diffuse and penetrate cell 
membrane freely in contrast to other signaling molecules which rely greatly on 
membrane receptors, exchangers and channels etc. As such, it would be logical to 
anticipate that H2S may possess diverse signaling pathways just like NO and CO. 
Discovering the downstream mechanisms of H2S would help to have a better 
understanding on this gasotransmitter and more importantly, to unveil even more 
physiological roles of H2S by studying their convergent paths at the downstream 
signaling level. As such, the main objective of my project is to further identify the other 
possible downstream signaling mechanisms activated by H2S using different cell types 







CHAPTER 1:  
 
REGULATION OF CALCIUM HOMEOSTASIS BY HYDROGEN 




2.1.1 Overview on microglia 
The mammalian central nervous system (CNS) consists of two major cell types, 
neurons and glia. Neurons are excitable cells and are directly involved in electrical 
transmission and information processing. In contrast, glia populations are non-excitable 
and thus carry out many indispensable functions both in development and during the 
normal function of the mature CNS (Jesson and Richardson, 2001; Alberdi et al., 2005). 
Glia population consists of macroglia, which includes astrocytes and oligodendrocytes, 
and microglia. Astrocytes mainly serve to provide structural support for the brain cells. In 
addition, astrocytes also play a part in the uptake of neurotransmitters, regulation of 
extracellular cation levels, and provision nutrients for the neurons (Alberdi et al., 2005). 
The other cell type of macroglia, the oligodendrocytes, produce myelin proteins such as 
myelin basic protein, proteolipid protein, myelin-associated glycoprotein and cyclic 
nucleotide phosphodiesterase which form the myelin sheath (Alberdi et al., 2005).  
In contrast to astrocytes and oligodendrocytes, microglial cells are the major 
immunocompetent element of the CNS which act as resident macrophages under normal 
physiological condition. Upon activation by disturbance in brain environment such as 
those under pathological conditions, they are rapidly activated and transformed into 
cytotoxic phacocytic cells. Resting microglia are characterized by their ramified 
morphology whereas activated microglia are characterized by ameboid morphology. 
Activated microglial cells can migrate to the site of infection, neurodegeneration and 
inflammation. They are usually stimulated by cytokines, neurotransmitters, and 
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neurotoxins etc which are usually present at site of inflammation. Upon stimulation, they 
may proliferate, synthesize and release a variety of factors such as cytokines, chemokines, 
NO, complements, cell adhesion proteins, reactive oxygen radicals and neurotrophins that 
could exert a damaging or a protective effect on adjacent neuron, axons, myelin and 
oligodendrocytes (Farber and Kettenmann, 2005). The activation of microglia affects 
many microglial properties including migration, proliferation, release of substances 
including NO and cytokines, phagocytosis or antigen presentation (Farber and 
Kettenmenn, 2006). 
 
2.1.2 Role of microglia in pathological condition 
 Activation of microglia has been reported in the brain of patients with 
neurodegenerative diseases such as Alzheimer’s (AD), Parkinson’s and Huntington’s 
diseases, multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) (Glezer, 2007). 
Up to date, controversies still exist on whether microglia is neuroprotective or 
neurodegenerative in the progression of these diseases. Recent work suggests that the 
activation of microglia initiates a cascade of inflammatory events which is first mediated 
by the pro-inflammatory cytokine interleukin 1 (IL-1). IL-1 generated from activated 
microglia causes neuronal death through release of proinflammatory cytokines, reactive 
oxygen intermediates, proteinases and complement proteins which activate more 
microglia. Under exhaustive condition, these potential cytotoxic molecules may in turn 
trigger the release of more IL-1 in a self-sustaining and self-amplifying fashion. Over a 
period of years, this slow, smoldering inflammation in the brain destroys sufficient 
neurons to cause the clinical signs of neurodegenerative diseases (Griffin, 2006). In the 
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case of AD in particular, the aggregation of the characteristic misfolded protein, β-
amyloid stimulates the microglial production of interleukins and other cytokines, leading 
to an ongoing inflammatory cascade and contributing to synaptic dysfunction and loss, 
and later, neuronal death in AD patients. As such, the progression of these 
neurodegenerative diseases should be at least partly contributed by the activation of 
microglia and neuroinflammation. However clinical trials designed to inhibit 
inflammation have failed in the treatment of AD patients suggesting that anti-
inflammatory agents have more protective than therapeutic effect (Zilka et al., 2006). It is 
possible that in determined conditions, microglia should be suppressed to avoid extended 
damage, while in other situations, restricting the innate immune response may impair 
regenerative processes and protection against invading pathogens (Glezer, 2007). 
 
2.1.3 Role of [Ca2+]i in the central nervous system 
Ca2+ is an essential element for neural function. The direct immediate role of Ca2+ 
in the CNS would be to trigger the release of neurotransmitter when the action potential 
arrives at the axon terminal. Ca2+ serves as an important second messenger in the nervous 
system together with cAMP, diacylglycerol (DAG) etc. Transient rise in cytoplasmic 
Ca2+ concentration represents a second messenger signal that controls many neuronal 
functions by triggering various biochemical reactions. One major effect of change in 
intracellular Ca2+ is on neuronal excitability, which is achieved by modifying the activity 
of membrane ion channels that regulate excitability and activity of ion channels such as 
Ca2+-dependent K+ channels (KCa channels) (Marsh et al., 2000). Moreover, Ca2+ often 
acts when it forms a complex with the small protein calmodulin (CaM). An important 
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example would be the activation of Ca2+/CaM-dependent protein kinase. Binding of the 
Ca2+/CaM complex to the protein kinase causes conformational changes of the kinase 
molecule that unfetter the catalytic domain for action. Activation of protein kinase 
phosphorylates many different target proteins, thereby altering their activities in dramatic 
ways which often lead to amplification and distribution of signals (Kandel et al., 2000).  
 
2.1.4 Role of [Ca2+]i in glia  
In glia, transient change in [Ca2+]i produces several short-term and long-term 
changes in glial function and structure. A transient increase in [Ca2+]i may quickly 
mobilizes arachidonic acid, which in turn results in an external accumulation of 
glutamate (Marin et al., 1991). In addition, KCa channels may be activated within seconds 
by a change in [Ca2+]i. Ca2+-activated protein kinases such as Ca2+/CaM dependent kinase 
and phospholipids-dependent PKC would serve to translate transient Ca2+ changes into 
longer lasting functional changes thorough phosphorylation of enzymes, ion channels and 
the cytoskeleton. Long term changes induced by [Ca2+]i increase include a change in glial 
gene expression, cytoskeletal remodeling, and glial proliferation and differentiation 
(Finkbeiner, 1995).  
In addition to the traditional second messenger role of [Ca2+]i in glial population, 
Ca2+ ions also serve as a form of long-range signaling mechanism which is termed Ca2+ 
signaling. Ca2+ signaling plays a critical role in various cell types by providing non-
excitable cells such as glial cells which do no generate or propagate action potential like 
neurons some form of “Ca2+ excitability” to communicate with each other and also 
exchange signals with neurons (Braet et al., 2004). There is accumulating evidence for 
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reciprocal interactions between glial Ca2+ waves and neurons. Neuronal activity evokes 
glia Ca2+ waves (Dani et al., 1992) and glial Ca2+ waves drive neuronal activity 
(Hassinger et al., 1995). The multiple interactions between neurons and glia strongly 
suggest that glial cells are integral modulatory elements in synaptic transmissions. 
Furthermore, it has been shown that microglia possesses Ca2+-mediated intracellular 
signaling with astrocytes (Verderio and Matteoli, 2001). Astrocytes communicate mainly 
via Ca2+ signaling which can propagate through the astrocytic syncitium over long 
distances and thus, modulate neuronal activity at a distant location (Jessen, 2004). 
Stimulation of astrocytes in brain slices evoked Ca2+ waves that spread to neighboring 
microglia (Schipke et al., 2002). 
 
2.1.5 Role of [Ca2+]i in microglia 
Ca2+ was proposed to serve as an integrator in microglia for various “classical” 
neurotransmitters as well as those for immune system mediators, which consequently 
control microglial behavior under resting and activated conditions (Hoffmann et al., 
2003). Under resting condition, microglia has a basal [Ca2+]i of ≈ 50 – 150 nM. Upon 
trigger, a transient rise in [Ca2+]i to hundreds of nM or even several µM within 
milliseconds can occur, and this is termed Ca2+ signaling in microglia.  
Classical experimental set ups has adopted LPS as a tool to stimulate and induce 
activation of microglia. Upon stimulation, a chronic elevation of basal [Ca2+]i in 
microglial cells (Hoffmann et al., 2003) was observed, along with a suppression of 
evoked Ca2+ signaling as indicated by reduced [Ca2+]i transients upon stimulation with 
UTP and complement C5a was observed. More importantly, the LPS-induced release of 
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NO and the cytokines TNF-α, IL-6, IL-12, macrophage inflammatory protein-1α, and the 
CXC chemokine KC are significantly attenuated in Ca2+-free environment. As such, an 
elevation of basal [Ca2+]i may be essential in regulating some executive functions in 
activated microglia (Hoffmann et al., 2003), suggesting a central role for Ca2+ in the 
inflammatory response of microglia in addition to Ca2+ signaling. 
 
2.1.6 Regulation of [Ca2+]i in microglia 
  Four processes are responsible for the tight regulation of [Ca2+]i: (1) Ca2+ influx; 
(2) Ca2+ release from internal stores; (3) Ca2+ extrusion from cytoplasm to extracellular 
space; and (4) Ca2+ sequestration into intracellular Ca2+ stores (Fig. 4). 
Ca2+ influx refers to the entry of Ca2+ ions from the extracellular space across the 
plasma membrane into cytosol via Ca2+ channels. Three types of channels are largely 
responsible for this influx: Ca2+ permeable receptor-operated channels (ROC) which are 
triggered by ligand binding, voltage-gated Ca2+ channels (VOC) which are activated by 
depolarization of the plasma membrane; and Ca2+-permeable store-operated channels 
(SOCs) which are opened upon depletion of intracellular Ca2+ stores and aid in 
replenishing the depleted Ca2+ stores. 
Ca2+ release from intracellular stores are mainly contributed by the inositol 1,4,5-
triphosphate (IP3) receptor (IP3R) family. Upon activation of G-protein coupled receptors 
(GPCR) or receptor protein kinases (RPKs), a specific isoform of phospholipase C (PLC) 
which convert membrane-bound phosphatidyl-inositol (4,5)-bisphosphate into IP3 and 
DAG would be activated. IP3 acts as a second messenger to bind the IP3Rs at ER, thus 
triggering Ca2+ release from ER internal stores.   
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 After the transient increase in [Ca2+]i, a much slower decay follows to resume the 
[Ca2+]i to the basal resting level. ATP-dependent Ca2+ pumps such as the Ca2+-ATPase in 
the plasma membrane maintain the steep Ca2+ gradient across plasma membrane by 
constantly extruding Ca2+ ions to the extracellular space. During high intracellular Ca2+ 
load, the Ca2+ pumps are aided by Na+/ Ca2+ exchangers which extrudes Ca2+ via 
manipulation of the Na+ gradient. Besides extrusion of Ca2+, a considerable amount of 
Ca2+ ions were sequestered into the internal stores for future release. The 
sarcoplasmic/endoplasmic Ca2+ ATPase (SERCA) located on the ER is responsible to 
replenish the depleted Ca2+ stores in ER. Mitochondria serve as a Ca2+ sink during times 































Fig 4. Regulation of [Ca2+]i and mechanism of Ca2+ signaling in microglia. ADP, 
adenosine diphosphate; ATP, adenosine triphosphate; GPCR, G-protein coupled receptor; 
IP3, inositol 1,4,5-triphosphate; IP3R, inositol 1,4,5 triphosphate receptor; Mito, 
mitochondrion; PLC, phospholipase C; ROC, receptor-operated channel; RPL, receptor 
protein kinase; RyR, ryanodine receptor; VOC, voltage-operated channel; ?, unknown 
signal (Adapted from Moller, 2002). 
 
2.1.7 Role of H2S on glia populations 
In addition to their neuromodulatory role in the neurons, H2S has also been shown 
to possess physiological functions in glia populations. Astrocyte is a major member of the 
glia cells. Astrocytes play an important role in maintaining neuronal excitability, 
regulating brain pH homeostasis, and uptaking various neurotransmitters such as 
glutamate around their synapses (Koehler et al., 2006). More importantly, a sufficiently 
large increase in [Ca2+]i in an astrocyte is capable of inducing and propagating a 
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spreading wave of increased intracellular Ca2+ termed “Ca2+ wave” in adjacent astrocytes 
(Dani et al., 1992). In contrast to neurons which transmit signals via generating action 
potential, astrocytes and other glial cells communicate with each other via Ca2+ signaling 
(reviewed by Braet et al., 2004). It provides a basis for astrocytes to act as a syncytium 
for possibly modulating neuronal and vascular function, suggesting the integral 
modulatory role of glia cells in synaptic transmission (Koehler et al., 2006; Braet et al., 
2004). Exogenous H2S elicits Ca2+ waves in primary cultures of astrocytes and 
hippocampal slices (Nagai et al., 2004). This Ca2+ wave triggered by H2S is also 
preceded by an increase in [Ca2+]i which occurs via Ca2+ influx through Ca2+ channels on 
the plasma membrane and to a lesser extent via Ca2+ release from intracellular Ca2+ store. 
In brain slices, this increase in [Ca2+]i caused by H2S spreads to the neighboring astrocyte 
population and triggers a Ca2+ wave.  
 Besides, H2S was shown to exhibit anti-inflammatory role in primary cultured 
microglia, BV-2 microglia cell line and astrocytes in a p38 MAP kinase dependent 
manner (Hu et al., 2007).  
 








2.2 Hypothesis and objectives 
A recent publication demonstrated that exogenous application of NaHS was able 
to induce Ca2+ waves in astrocytes but not in neurons (Nagai et al., 2004). However, the 
investigation of the role of endogenous H2S in regulation of Ca2+ homeostasis in other 
brain cells is still needed. In view that H2S was shown to trigger Ca2+ waves in astrocytes 
and astrocytic Ca2+ waves trigger responses in microglia cells in brain slices, it would be 
interesting to look into the intracellular Ca2+ response of microglia triggered by H2S. 
Moreover, H2S increases the production of cAMP (Kimura, 2000), which is well known 
















2.3 Materials and methods 
 
2.3.1 Cell culture – preparation of primary cultured microglia 
Experiments were approved by the animal ethics committee of National 
University of Singapore and carried out in accordance with established Guiding 
Principles for Animal Research. 
Microglia cells were prepared from cortex of newborn 3-4 day-Sprague Dawley 
(SD) rats as described (Zhou et al., 2005), with minor modification. In brief, cortex 
tissues, devoid of meninges and blood vessels, were minced and digested with 0.2% 
trypsin (Sigma, St. Louis, MO, USA) followed by 0.01% DNase1 (Sigma, St. Louis, MO, 
USA). The cells were dissociated by mild mechanical trituration and cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS, 2 mM L-
glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin maintained at 37ºC in a 
humidified atmosphere of 5% CO2/95% air, with change of medium every three day. On 
reaching confluence (10-14 days), the microglial cells were separated from the 
underlying astrocytic monolayer by gentle agitation using their differential adhesive 
properties. The floating microglial cells were plated on sterilized glass coverslips situated 
in culture dishes. Non-adhesive cells were removed by washing in phosphate-buffered 
saline (PBS). To test the purity of the culture, the cells were stained with Griffonia 





2.3.2 Reverse transcription- polymerase chain reactions (RT-PCR) 
To exclude the possible contamination of the microglia culture by  astrocytes, 
total RNA of primary cultured microglia and astrocytes (positive control) were isolated to 
detect glial fibrillary acid protein (GFAP, a specific marker of astrocyte) mRNA by using 
RT-PCR. To detect CBS and CSE mRNA expression, total RNA was isolated from 
primary cultures of rat microglia. Total RNA from adult rat hippocampus was used as a 
positive control for CBS expression. Briefly, cells or brain tissues were lysed directly in 
culture dishes with Trizol® Reagent (Life Technologies) when a confluency of 
approximately 90% was reached. Phase separation was carried out by subjecting the cells 
to exhaustive phenol-chloroform extraction. Total RNA was precipitated with 
isopropanol and washed with 75% ethanol. Concentration of the RNA was determined by 
spectrophotometer at absorbance 260nm and 280nm.  
 RT-PCR was carried out using QIAGEN® one-step RT-PCR kit (Qiagen Ltd, 
U.S.A.). The intron-spanning primers of CSE and CBS were designed. To examine the 
mRNA level of GFAP, CBS and CSE in rat primary cultured microglia cells and 
astrocytes, the following primers were used: 
Target enzymes Primer sequence Product size (bp) 
Forwards: 95 5’-attccgcgcctctccctgtctc-3’ 
Rat GFAP 
Reverse: 531   3’-gcttcatccgcctcctgtctgt-5’ 
437 
Forward: 568 5’-gccaacttctggcaacac-3’ 
Rat CBS 
Reverse: 892 5’caccagcatgtccaccttc-3’ 
324 
Forward: 441 5'-tctgtggtgtgatcgctg-3' 
Rat CSE 
Reverse: 242 5'-aagcagtggctgcactgg-3' 
234 
 
Table 3: Primer sequences for the detection of rat GFAP, CBS and CSE and their 
respective product size. 
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RT-PCR for CBS and CSE was conducted in a touchdown manner. Reverse 
transcription was performed at 56ºC for 8 min, 55 ºC for 10 min, 53 ºC for 8 min, 51 ºC 
for 8 min, 45 ºC  for 10 min and at 95ºC for 15 min. For polymerase chain reaction, one 
cycle of denaturation at 94 ºC for 20 sec, annealing at 56 ºC for 20 sec and elongation at 
72 ºC was performed. The annealing temperature was decreased by 1 ºC at each cycle and 
finally, 34 cycles with an annealing temperature of 45 ºC was performed. PCR products 
were analyzed with 1% agarose gel electrophoresis and imaged by the Multigenius 
Bioimaging system (Syngene, U.K.).  
 
2.3.3 Measurement of [Ca2+]i 
Adherent cells cultured on sterilized coverslips were incubated with 4 µM fura-2/AM 
for 30 min in DMEM. The unincorporated dye was removed by washing the cells twice 
in fresh incubation solution. Loaded cells were maintained at room temperature for 30 
min before measurements of [Ca2+]i in order to allow any fura-2/AM in the cytosol to de-
esterify. Cells loaded with fura-2/AM were transferred to the stage of an inverted 
microscope (Nikon Ltd, Japan) in a superfusion chamber at room temperature. The 
inverted microscope was coupled with a dual-wavelength excitation spectrofluorometer 
(Intracellular imaging Inc, USA). Cells were perfused with Krebs’ bicarbonate buffer 
(mM): 117 NaCl, 5.4 KCl, 1.2 MgSO4, 1.2 KH2PO4, 1.3 CaCl2, 25 NaHCO3, 11.7 
glucose, pH 7.4) or EGTA-treated Ca2+-free Krebs bicarbonate buffer (mM): 2 EGTA, 
117 NaCl, 5.4 KCl, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 11 glucose, pH 7.4). Drugs 
were added directly into the bathing solution during Ca2+ measurement and the change in 
fluorescent intensity was monitored. 
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The ratio of fluorescent signals obtained at 340 nm (F340) and 380 nm (F380) 
excitation wavelengths were recorded. F340/F380 ratio (R) was used to represent the 
[Ca2+]i in the cells. R/R0 was employed to assess the change in [Ca2+]i, where R0 
represents the fluorescent signal before drug treatment and R represents the fluorescent 
signal after drug treatment.  
 
2.3.4 Chemicals 
Sodium hydrosulphide (NaHS), amino-oxyacetate (AOAA), β-cyano-L-alanine 
(BCA), D,L-propargylglycine (PAG), thapsigargin, H-89 and gadolinium chloride (GdCl3) 
were obtained from Sigma-Aldrich, St. Louis, MO, USA. Chelerythrine and U73122 
were purchased from Calbiochem, Darmstadt, Germany. Fura-2/AM was obtained from 
Molecular Probes, Eugene, OR, USA. All chemicals were dissolved in water except 
thapsigargin, H-89, chelerythrine, U73122 and Fura-2/AM which were dissolved in 
dimethyl sulphoxide (DMSO). 
Like numerous previous researchers, NaHS was adopted as a donor for H2S. When 
NaHS is dissolved in water, HS- is released and forms H2S with H+. This provides a 
solution of H2S with better defined concentration both in terms of accuracy and 
reproducibility when compared to a solution obtained by bubbling H2S gas into water 
(Abe and Kimura, 1996; Nagai et al., 2004). It has been shown that the actual yield of 





2.3.5 Statistical analysis 
Paired Student’s t-test was used to determine the difference in [Ca2+]i before and after 
treatment in the same cell. One-way analysis of variance (ANOVA) with a post-hoc 
(Bonferroni) test was employed to determine the difference among groups. Significance 





















2.4.1 Expression of GFAP in primary cultured rat astrocytes, but not in microglia 
To confirm the purity of the primary cultured microglia, the mRNA expression of 
GFAP, a specific marker of astrocyte, was examined in primary cultured microglia and 
astrocytes. As shown in Fig. 5, with the same amount of RNA loaded, the mRNA 
expression of GFAP was only detected in primary cultured astrocytes but not in primary 
cultured microglial cells, suggesting that the primary cultured microglial cells were not 











Fig. 5. RT-PCR showing the expression of GFAP in astrocytes but not in microglia. 
GFAP was detected in primary cultured astrocytes (left lane) but not in primary cultured 
microglia (right lane) (n=2). 
 
2.4.2 Effects of NaHS on [Ca2+]i in microglial cells 
As shown in Fig 6, NaHS (a donor of H2S) at 0.1, 0.3 and 0.5 mM dose-dependently 
increased [Ca2+]i in primary cultures of microglial cells (Fig. 6B, 6C). At the highest 
concentration used, [Ca2+]i was increased by about 20% (Fig. 6A). Previous study has 
shown that the actual yield of H2S is approximately 33% of the amount of NaHS 
(Reiffenstein et al., 1992). As such NaHS at the above concentrations may produce 
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approximately 33, 99 and 165 µM H2S, which are within the reported physiological 
concentration range (Warenycia et al., 1989). As seen in the representative tracings in Fig. 
6A and 6B, the effect of H2S occurred rapidly after administration of NaHS. When NaHS 
was being washed away via the perfusion system, the [Ca2+]i level decreased  to the 
original level, demonstrating the reversibility of the effect of H2S (Fig. 6A). This is 






























































Fig. 6. Concentration-dependent effect of NaHS on [Ca2+]i in primary cultured rat 
microglial cells. (A) Representative tracing showing the reversible effect of NaHS when 
NaHS was being washed away; (B) Representative tracings showing the effect of NaHS 
at 0.1, 0.3 and 0.5 mM in primary cultured microglial cells; (C) Results shown in mean ± 
SEM, ***p<0.001 compared with [Ca2+]i before NaHS treatment in the same group. The 
experiment was carried out in five coverslips from different preparation, each containing 
14-22 cells. 41/71 cells were responding.  
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2.4.3 Effect of NaHS on [Ca2+]i in the absence of extracellular Ca2+ source and in 
the presence of Ca2+ channels inhibitor 
 In this series of experiments, the mechanisms of NaHS-induced [Ca2+]i elevation 
in microglial cells was examined. To determine the contribution of Ca2+ influx, EGTA-
treated, Ca2+-free Krebs bicarbonate buffer ([Ca2+]o=0) was employed. After bathing the 
cells in Ca2+-free Krebs bicarbonate buffer for 10 min, 0.3 mM NaHS was added. As 
shown in Fig. 7A, the [Ca2+]i elevation in response to NaHS was partially attenuated by 
43.3 ± 1.1% in Ca2+-free medium (Fig. 7C). To assess the involvement of Ca2+ channels 
in the NaHS-induced [Ca2+]i elevation in primary microglial cells, trivalent cation, Gd3+, 
a potent non-selective blocker of Ca2+ channels (Nagai et al., 2004), were employed. At 
100 µM, Gd3+ partially suppressed the effect of NaHS by 38.3± 0.8% (Fig. 7B & 7C), 
which is not significantly different from the results obtained in Ca2+-free medium. These 













































































Fig. 7. Effect of NaHS on [Ca2+]i in primary cultured rat microglial cells in the absence 
and presence of Gd3+ (100 µM) or maintained in the EGTA-treated, Ca2+-free solution. 
(A-B) Representative tracings showing the effect of 0.3 mM NaHS on [Ca2+]i in 
microglial cells. Cells were treated with Ca2+-free Krebs bicarbonate buffer (A) or Gd3+ 
(B) for 5 min and 20 min before and after NaHS treatment, respectively. (C) Results 
shown in mean ± SEM, ***p<0.001 compared with control. Ca2+-free experiment (A) 
was carried out in four coverslips each containing 7-20 cells, 47/63 cells were responding; 
Gd3+ experiment (B) was carried out in three coverslips each containing 9-18 cells, 31/38 
cells were responding.  
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2.4.4 Effect of NaHS on [Ca2+]i after depletion of intracellular Ca2+ store 
The endoplasmic reticulum (ER) is an important intracellular Ca2+ store. To 
determine the involvement of the ER in the response of microglia to NaHS, thapsigargin, 
a SERCA blocker was employed. The intracellular Ca2+ store in ER was depleted by 
incubating cells with 2 µM thapsigargin for 60 min in DMEM prior to the application of 
0.3 mM NaHS. As shown in Fig. 8A and 8B, the response to NaHS was suppressed by 
thapsigargin treatment by 37.5 ± 1.2%. These data showed that the intracellular Ca2+ 
store in the ER, together with extracellular Ca2+, are responsible for the elevation of 





















































Fig 8. Effect of NaHS on [Ca2+]i in primary cultured rat microglial cells in the absence 
and presence of thapsigargin (2 µM). (A) Representative tracings showing the effect of 
0.3 mM NaHS on [Ca2+]i in microglial cells. Cells were treated with thapsigargin for 60 
min before and after NaHS treatment, respectively. (D) Results shown in mean ± SEM, 
***p<0.001 compared with control. The experiment was carried out in three coverslips 





2.4.5 Effect of NaHS on [Ca2+]i in the presence of PKA inhibitor 
 To examine whether cAMP/PKA pathway is involved in the [Ca2+]i elevation 
upon NaHS treatment, H-89 (15 µM), a selective PKA inhibitor, was employed. As 
shown in Fig. 9, H-89 suppressed [Ca2+]i response to NaHS by 26.3± 1.8%, suggesting 



















































Fig. 9. Effect of NaHS on [Ca2+]i in primary cultured rat microglial cells in the absence 
and presence of H-89 (15 µM). (A) Representative tracings showing the effect of 0.3 mM 
NaHS on [Ca2+]i in microglial cells in the absence and presence of H-89. Cells were 
treated with H-89 for 20 min before and after NaHS treatment, respectively. (B) Results 
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shown in mean ± SEM, **p<0.01 compared with control. The experiments were 
performed in 4–5 coverslips in different preparations, each coverslip containing 8–22 
cells. 41/ 71 cells were responding. 
 
2.4.6 Effect of NaHS on [Ca2+]i in the presence of PKC inhibitor and PLC 
inhibitor 
 This series of experiments was designed to determine the involvement of 
PLC/PKC/IP3 pathway in the action of H2S. As shown in Fig. 10, neither U73122 (5 µM), 
a PLC inhibitor, nor chelerythrine (1 µM), a selective PKC inhibitor, attenuated H2S-







































































Fig. 10. Effect of NaHS on [Ca2+]i in primary cultured rat microglial cells in the absence 
and presence of U73122 (1 µM) or chelerythrine (1 µM). (A, B) Representative tracings 
showing the effect of 0.3 mM NaHS on [Ca2+]i in microglial cells. Cells were treated with 
U73122 (A) or chelerythrine (B) for 15 and 5 min before and after NaHS treatment 
respectively. (C) Results shown in mean ± SEM, no statistical difference was found when 
compared with control. U73122 experiment was carried out in two coverslips from 
different preparations, each coverslip containing 20-23 cells, 13/43 cells were responding. 
Chelerythrine experiment was carried out in two coverslips from different preparation, 
each coverslip containing 27-32 cells, 26/59 cells were responding.  
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2.4.7 Expression of CBS and CSE in primary cultures of rat microglia 
 As shown in Fig. 11, the mRNA expression of CSE, but not CBS, was detected in 
primary cultured rat microglial cells (Fig. 11 left two lanes). However, the expression of 
CBS in adult rat hippocampus was detected (Fig. 11 right lane), further confirming that 











Fig. 11. Expression of H2S-producing enzymes in primary cultured rat microglial cells. 
RT-PCR showing the expression of CSE, but not CBS, in primary cultured microglial 
cells; left two lanes: primary cultured rat microglial cells, Right lane: rat adult 
hippocampus, n = 2.  
 
2.4.8 Effects of CBS and CSE inhibitors on [Ca2+]i in microglia  
With the aforementioned data in mind, the effect of endogenous H2S on [Ca2+]i was 
examined by inhibiting CSE. PAG (Stipanuk and Beck, 1982; Uren et al., 1978) and 
BCA (Pfeffer and Ressler, 1967; Uren et al., 1978) are potent inhibitors of CSE. As 
shown in Fig. 12, both PAG and BCA caused significant decrease in [Ca2+]i in primary 
cultured microglial cells, reaching about 10–20% reduction (Fig. 12C). The effects of 


























































Fig. 12. Effects of CSE inhibitors on [Ca2+]i in primary cultured rat microglial cells. (A, 
B) Representative tracings showing the effect of 2 mM PAG (A) and 2 mM BCA (B) on 
[Ca2+]i. (D) Results of CSE inhibitors shown in mean ± SEM, **P <0.01 compared with 
control. PAG experiment was carried out on three coverslips in different preparations, 
each coverslip containing 30–34 cells, 20/95 cells were responding. BCA experiment was 
carried out in three coverslips in different preparations, each coverslip containing 6–36 







In the present study, NaHS (0.1 to 0.5 mM) was shown to increase [Ca2+]i in primary 
cultured microglial cells concentration-dependently. [Ca2+]i response to 0.3 mM NaHS 
(which yielded approximately concentration of 99 µM H2S) was mediated partly by an 
influx of Ca2+ from the extracellular solution and partly due to release from intracellular 
Ca2+ stores. This is consistent with a recent study which has shown that H2S-induced Ca2+ 
waves in astrocytes also involves both Ca2+ influx and intracellular Ca2+ stores (Nagai et 
al., 2004).  
 
2.5.2 Mechanisms of action of H2S on ion channels 
 The mechanism by which H2S opens Ca2+ channels in the cell membrane is not 
clear. However, H2S, as a gas, is likely to infiltrate the three dimensional structure of 
receptors, enzymes and channels and may conceivably alter their conformation so that 
their functions are altered (Moore et al., 2003). Thus, H2S may regulate [Ca2+]i in 
microglial cells either directly by activating the Ca2+ channels or indirectly by activating 
other enzymes, or both. 
 
Ca2+ influx across the microglial plasma membrane may, in principle, occur via 
several types of channels in the cell membrane. One type of the channels is the Ca2+-
permeable ROCs. These receptors include glutamate activated receptors and P2 receptors 
(formerly called purinoceptor) (Moller, 2002). Glutamate is the most abundant excitatory 
neurotransmitter in the central nervous system. It activates ionotropic [NMDA, α-amino-
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3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) and Kainate] receptors as well as 
metabotropic receptors. Microglial cells express AMPA and kainate (primarily GluR5) 
subtypes of glutamate receptors (Noda et al., 2000) which are primarily permeable to Na+ 
ions. These receptors are unlikely to be a significant contributor to H2S-induced [Ca2+]i 
elevation due to their low Ca2+ permeability, which is undetectable under normal ionic 
conditions (Noda et al., 2000). Furthermore, microglial cells do not express NMDA 
receptors (Farber and Kettenmann, 2005) and therefore the possibility of the involvement 
of NMDA receptors in the Ca2+ response to H2S seems unlikely. P2 receptors are 
activated by purines and pyrimidines (e.g., ATP, UTP, and ADP). Functional P2 
receptors trigger [Ca2+]i signals in microglial cells in situ (Moller et al., 2000) and P2 
receptors appear to be involved in astrocyte-microglial signaling (Verderio and Matteoli, 
2001). More experiments are needed to determine the involvement of P2 receptors in the 
action of H2S.  
A second type of channels is the voltage-operated Ca2+ channels (VOCs). They are 
activated by depolarization of the plasma membrane. Since no expression and function of 
VOCs have been demonstrated in microglia (Farber and Kettenmann, 2005; McLarnon et 
al., 1999) these channels may also not be involved in H2S-induced [Ca2+]i elevation. A 
third type of channels is Ca2+ permeable store-operated channels (SOCs). SOCs are 
opened upon depletion of intracellular Ca2+ stores and aid in replenishing the Ca2+ 
depleted stores. More experiments are needed to determine the involvement of P2 




2.5.3 Role of protein kinases on the effect of H2S on [Ca2+]i 
In the present study, the signaling mechanism of the action of H2S was also 
investigated. A previous study has shown that H2S activates cAMP/PKA pathway in both 
neuronal and glial cells (Kimura, 2000). PKA may in turn phosphorylate and activate 
several types of Ca2+ channels including the Ca2+ release-activated Ca2+ (CRAC) 
channels, a kind of highly Ca2+-selective SOCs (Hahn et al., 2000; Rossie, 1999; Wu et 
al., 1999). It was found that blockade of PKA with its specific antagonist, H-89, 
significantly attenuated the effect of NaHS, suggesting that activation of cAMP/PKA 
pathway may open Ca2+ channels such as CRAC channels and therefore increase [Ca2+]i. 
On the other hand, a PLC inhibitor, U73122, and a PKC inhibitor, chelerythrine, failed to 
affect the action of H2S on intracellular Ca2+ store. This excludes the possibility that the 
PLC/PKC/IP3 pathway mediates H2S-induced [Ca2+]i elevation, although H2S 
preconditioning could activate PKC in cardiac myocytes (Bian et al., 2006) and 
activation of PKC may regulate Ca2+ content in intracellular Ca2+ store (Bian et al., 
1998a,b). 
 
2.5.4 Expression of CBS and CSE in microglia 
 To further determine the effect of H2S in regulating intracellular Ca2+ level in 
microglia, the role of endogenous H2S was investigated. Endogenous H2S is generated in 
mammalian tissues by two pyridoxal-5’-phosphate-dependent enzymes, CBS and CSE, 
both using L-cysteine as substrate. High CBS transcript mRNA levels in rat hippocampus 
and cerebellum with a relatively high expression in the cerebral cortex and brainstem has 
been previously detected using northern blot analysis (Abe and Kimura, 1996). Thus, it 
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has been suggested that CBS is the major H2S-producing enzyme in brain. CSE 
expression (as detected by PCR) is relatively low (Erickson et al., 1990). In the present 
study, the expression of CBS and CSE in primary cultures of rat microglia was 
determined. Interestingly, only CSE expression was observed in primary cultures of 
microglia. This could be caused by the spatial and temporal expression patterns of CBS 
during development as previously reported in mice (Enokido et al., 2005; Robert et al., 
2003) and human (Quere et al., 1999). The CBS expression declines in the nervous 
system in the late embryonic stages, whereas it increases gradually in the brain after birth, 
peaking during cerebellar development (Robert et al., 2003). The primary cultures of 
microglia in the present study were prepared from 2-3 days postnatal rats which have a 
lower CBS expression level in contrast to adult mice. This could cause them to be 
undetectable in the RT-PCR measurement. Moreover, immunohistochemistry and in situ 
hybridization study has revealed that no significant CBS expression was detected in 
microglia cell population (Enokido et al., 2005), which further supports the current 
findings. Taken together, these studies suggest that distribution of these two enzymes in 
different cell types in the brain may well differ significantly.  
  
2.5.5 Role of endogenous H2S on [Ca2+]i in microglia 
 Since only CSE mRNA expression was detected, endogenous H2S production in 
primary cultured microglial cells was decreased using CSE inhibitors only. Various 
studies had demonstrated that these drugs could effectively inhibit the endogenous H2S 
production in vivo (Mok et al., 2004) in tissue homogenates (Abe and Kimura, 1996; 
Hosoki et al., 1997) and in cell cultures (Drake et al., 1987; Tang et al., 2005). All these 
 57 
findings suggested that both drugs are cell membrane permeable drugs and are potent 
H2S-producing enzyme inhibitors. PAG is an irreversible inhibitor of CSE that crosses 
biological membrane readily (Reed, 1995; Stipanuk and Beck, 1982; Uren et al., 1978), 
whereas BCA causes reversible inhibition of CSE activity (Pfeffer and Ressler, 1967; 
Uren et al., 1978). However, in the present study, BCA produced reversible action after 
washout for 20 min only in very few cells. This is supported by a previous study that 
BCA produces reversible effect only when the substrates (L-cysteine or D,L-homoserine) 
of CSE were 10 times higher than normal concentration (Pfeffer and Ressler, 1967). Thus, 
it is likely that under the current experimental conditions, the L-cysteine level in most 
cells was not high enough to reverse the effect of the CSE inhibitor. 
 The present data suggests that H2S plays a role in the regulation of Ca2+ 
homeostasis in microglia. Besides its role as a second messenger, Ca2+ ions serve as an 
integrator to control microglial behavior under resting and activated conditions, with 
elevated basal Ca2+ concentration being a characteristic of activated microglia cells after 
LPS challenge (Hoffmann et al., 2003). With the readily diffusible property of H2S, it 
would be logical to anticipate that H2S might play a role in activating neighboring 









2.5.6 Conclusion and significance 
In summary, H2S increased [Ca2+]i in primary cultures of microglia. The elevated 
[Ca2+]i was contributed by both Ca2+ influx across the cell membrane via Ca2+ channels 
and Ca2+ release from intracellular Ca2+ stores. cAMP/PKA, but not PLC/PKC/IP3  
pathway, mediates this effect. Besides, the main H2S-synthesizing enzyme in microglia 
population is CSE rather than CBS which is widely expressed in the brain. More 
importantly, inhibition of H2S synthesis decreased the basal level of [Ca2+]i. These data 
provided the first evidence that endogenous H2S mediates [Ca2+]i regulation in microglial 










REGULATION OF INTRACELLULAR pH BY HYDROGEN 





3.1.1 Overview of intracellular pH 
 Intracellular pH (pHi) refers to the concentration of hydrogen (H+) ions in the 
cytosol. In most mammalian cell types, pHi is tightly regulated at a range of 7.1-7.2 
(Puceat, 1999) which is slightly acidic than the extracellular environment (pH 7.4). 
Proteins require a specific range of pH for optimal functioning. A change in pHi could 
influence the activity of various enzymes and ion channels (La Pointe and Batlle, 1996). 
As such, pHi regulates many cellular processes, including cell metabolism, Ca2+ 
homeostasis, gene expression, cell motility and contractility, cell-cell coupling, cell 
adhesion and cell death (Puceat, 1999).  
 
3.1.2 Role of pHi in vascular smooth muscle 
For decades, intracellular pH (pHi) has been shown to play an important part in 
regulating vascular tone. Although some exceptions exist between different types of 
vascular tissues, it is widely accepted that alkalinization causes an increase in vascular 
tone whereas acidification has the opposite effect. Generally, change in pHi alters [Ca2+]i, 
which may bring about changes in force. pHi regulates [Ca2+]i via modulation of various 
ions channels, Ca2+ pumps and intracellular Ca2+ stores etc (Wray and Smith, 2004) 




3.1.3 Regulation of pHi in vascular smooth muscle 
Resting pHi in vascular smooth muscle is normally close to 7.1 (Smith et al., 
1998). Two major mechanisms are responsible for the tight regulation of pHi in vascular 
smooth muscle: (i) the intrinsic buffering buffer which consists of HCO3-/CO2 system and 
intracellular proteins which caters for sudden abrupt changes in pHi and (ii) the tight 
regulation by several ionic exchangers. These exchangers can be broadly divided into 














Fig.13. Regulation of pHi in vascular smooth muscle cells. NHE, Na+/H+ exchanger; Cl-
/HCO3- exchanger, Na+-independent chloride bicarbonate exchanger; Ca2+ ATPase, 
plasmalemmal calcium-ATPase. 
  
In A7r5 aortic smooth muscle cells and most vascular smooth muscle cells, the 
Na+/H+ exchanger (NHE) is the main acid extruder. It is responsible for rapid recovery of 
pHi from an acid load by extruding H+ in exchange for extracellular Na+. NHE was 
usually activated by acidic cellular conditions to catalyze the electroneutral exchange of 
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one extracellular Na+ ions for one intracellular H+ ion. In addition to pHi regulation, NHE 
was shown to regulate the expression of several genes in cell cycle progression (Putney 
and Barber, 2004), plays a role in cell differentiation (Wang et al., 1997) and to maintain 
cytoskeletal structure (Denker and Barber, 2002). The activity of this pump has been 
linked to disease states including diabetes and hypertension (Huot and Aronson, 1991).  
In contrast, the Na+-independent Cl-/HCO3- exchanger acts as an acid loader by 
translocating intracellular HCO3- in exchange for extracellular Cl-. HCO3--dependent pHi 
regulation was found to dominate NHE-mediated pHi regulation in A7r5 cells (Vigne et 
al., 1988). Cl-/HCO3- exchanger are expressed since very early during embryogenesis for 
recovery of pHi from alkaline load, which plays a key role for embryo living in alkaline 
uterine environment (Baltz, 1993). In addition to pHi regulation, the exchangers also 
played a role in modulating Cl- and HCO3- homeostasis in tissues such as stomach and 
kidney. On the other hand, Cl-/HCO3- exchangers regulate cell volume by releasing the 
ions in response to cell swelling in a concerted manner with other exchangers (Motais et 
al., 1997). 
 
Besides the Cl-/HCO3- exchanger, the plasmalemmal Ca2+-ATPase is another acid 
loader although its importance does not seem to be as great as Cl-/HCO3- exchanger (La 
Pointe, 1996). Ca2+-ATPase extrudes Ca2+ from cytosol in exchange for two protons 
which in turn may lead to a decrease in pHi. The involvement of these exchangers/pumps 




3.1.4 Mechanisms of vasorelaxation 
In general, vasoconstriction can either be induced by depolarization or binding of 
agonist, both of which resulted in an increase in [Ca2+]i in the smooth muscle cells. The 
increased Ca2+ ions in the cytosol will in turn bind to CaM to form Ca2+-CaM complex. 
Binding of Ca2+/CaM to myosin-light-chain kinase (MLCK) would activate this kinase, 
which is responsible for the phosphorylation of Ser-19 myosin light chain (MLC) (Hai 
and Murphy, 1989). Upon phosphorylation, MLC detached from the actin filament to 
generate force. To initiate relaxation, a second enzyme, myosin light chain phosphatase 
















Fig. 14. Mechanisms of vasoconstriction and vasorelaxation in vascular smooth muscle. 
CaM, calmodulin; IP3R, inositol 1,4,5-triphosphate receptor; MLCK, myosin light chain 
kinase; MLCP, myosin light chain phosphatase; ROC, receptor operated Ca2+ channels. 
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3.1.5 Relationship pHi and [Ca2+]i 
Several studies have pointed out that pHi regulates contractility via modulating 
the sensitivity of contractile proteins to Ca2+. As such, proteins such as Ca2+/CaM 
complex, MLCK and MLCP may serve as the target responsible for the change in 
contractility. CaM is a negatively charged protein. H+ ions are released when Ca2+ binds 
to CaM, suggesting that acidic pH would reduce and alkaline pH would enhance the 
affinity of calmodulin for Ca2+ (Milos et al., 1986). Huang and Cheung suggest that the 
binding of H+ to MLCK exposes an amphiphathic domain that is complementary to that 
on CaM and allows the two proteins to interact. They further propose that the H+ release 
on Ca2+ binding to CaM may play an important role in facilitating the interaction between 
CaM and MLCK (Huang and Cheung, 1994). However, most of these studies lack firm 
evidences to support the view that pHi directly alters the sensitivity of these contractile 
proteins to Ca2+. 
More attentions have been placed on the effect of pHi on the Ca2+ release from 
intracellular Ca2+ stores. Ca2+ release can be either via Ca2+-induced Ca2+-release or IP3-
induced Ca2+ release. Ca2+-induced Ca2+ release is initiated by an increase in [Ca2+]i 
outside the SR which eventually triggers Ca2+ release via the activation of ryanodine 
sensitive channels in the SR membrane. Ca2+-induced Ca2+ release was shown to be 
sensitive to pHi in smooth muscle fiber (Iino M, 1989), skeletal muscle and cardiac 
muscle preparation where an increased pH increased the sensitivities of the channels to 
Ca2+ (Fabiota and Fabiota, 1978). As such, acidosis would depress the Ca2+-induced Ca2+ 
release leading to vasorelaxation. IP3-induced Ca2+ release was usually initiated by the 
binding of agonists. IP3R would be activated to release Ca2+ in SR stores. Several studies 
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have suggested the pH dependency of IP3-induced Ca2+ release where a rise in pHi 
increased the sensitivity of the IP3-induced Ca2+ release in portal vein (Tsukioko et al., 
1994) and rabbit aortic smooth muscle (Murphy et al. 1995).  
In addition to the effect on Ca2+ release, several studies have also pointed out a 
role for L-type Ca2+ channels for the altered contractility (Iino et al., 1994; Shmigol et al., 
1995; Otter and Austin, 2000; Wakabayashi et al., 2001). In general, intracellular 
acidification decreases, and alkalinization increases, Ca2+ influx through these channels. 
It was suggested that the effects of pHi on the L-type channel was due to 
protonation/deprotonation of a cytosolic binding site which shifted the channel from a 
“sleepy” to an “available” state (Klockner and Isenberg, 1994). 
 
3.1.6 H2S induced vasorelaxation 
A role for H2S in the regulation of vascular tone was first suggested by Zhao and 
colleagues (Zhao et al., 2001).  Endogenous H2S is generated in vascular tissue mainly 
from CSE. Exogenous application of H2S relaxes aortic rings in vitro and decreases blood 
pressure in intact rats (Zhao et al., 2001). The vasodilatory effect was not only observed 
in thoracic aorta, but also in mesenteric arteries (Cheng et al., 2004), ileum (Teague et al., 
2002) and portal vein (Hosoki et al., 1997). Despite the finding that H2S can cause 
vasorelaxation by activating KATP channels (Zhao et al., 2001), the precise signaling 
mechanism for the effect of H2S on vascular tone is still not clear. The role of NO, cAMP, 
prostaglandin, PKC and ROS were all negated in this study. Interestingly, Zhao et al. 
(2001) have shown that application of NaHS, a H2S donor, causes vasodilation of rat 
aortic ring in a concentration-dependent manner starting from 60 µM. However, it was 
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recently reported that NaHS produced contraction of rat aortic rings at concentrations as 
low as 10 – 100 µM NaHS (Ali et al., 2006). Moreover, Ali et al. have suggested that 
H2S and NO may react together to form a molecule (possibly a nitrosothiol) which 
exhibits little or no vasorelaxant activity either in vitro or in vivo (Ali et al., 2006). They 
have proposed an additional role of H2S in the vascular system: regulation of the 
availability of NO. In addition, H2S exerts contraction or relaxation (or both) of blood 


















3.2 Hypothesis and objectives 
 As a biological gas, H2S has been shown to possess various physiological roles. In 
terms of regulation on vascular tone, most studies have suggested a central role for the 
activation of KATP channels. However, recently, with different experimental set ups and 
species, the vasoconstrictor property of H2S has been unveiled. In addition, blockade of 
KATP channels with 10 µM glibenclamide, which is the optimal concentration used in 
most studies, failed to completely abolished the vasodilatory effect of H2S, suggesting the 
independent additional mechanisms involved in the vasorelaxation induced. This opens 
an intriguing additional field of enquiry and suggests that KATP channels may not be the 
only signaling mechanism by which H2S brings about vasorelaxation. In view of the 
potent effect of acidosis to trigger vasorelaxation, I hypothesize that H2S may induce 













3.3 Materials and methods 
 
3.3.1 Cell culture 
 A7r5 cells, derived from rat BD1X embryonic rat aortic smooth muscle, were 
purchased from American Type Culture Collection (Rockville, MD, USA). They were 
cultured in DMEM (GIBCO, Grand Island, NY) supplemented with 10% fetal bovine 
serum and 1% antibiotics (streptomycin and penicillin). Medium was changed every 
other day and grown at 37ºC with 95% oxygen and 5% CO2. For pHi measurements, cells 
were cultured on sterilized glass coverslips. Coverslips with cells grown at near confluent 
were used.    
 
3.3.2 Measurement of pHi 
BCECF/AM, a pHi sensitive fluorescent indicator, was used to monitor the 
change in pHi. Adherent cells cultured on sterilized coverslips were incubated with 5 µM 
BCECF/AM for 30 min in DMEM at room temperature. The unincorporated dye was 
removed by washing the cells twice in fresh incubation solution. Loaded cells were 
maintained at room temperature for 30 min before measurements of pHi to allow any 
BCECF/AM in the cytosol to de-esterify. Coverslips with cells loaded with BCECF/AM 
were transferred to the stage of an inverted microscope (Nikon, Japan) in a superfusion 
chamber at room temperature. The chamber was equipped for rapid superfusion of cells 
with solutions of different pH for calibration of the pHi measurement system. The 
inverted microscope was coupled with a dual-wavelength excitation spectrofluorometer 
(Intracellular imaging, USA) which illuminated the cells alternatively with light at 
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wavelengths of 440 nm and 490 nm. The ratio of fluorescence signals at 490 nm to 440 
nm was used as an estimation of pHi.  
Cells were perfused with Krebs' bicarbonate buffer during experiment. Drugs 
were added directly into the bathing solution during pHi measurement and the changes in 
fluorescent intensity were monitored. Fluorescent signals obtained at excitation 
wavelengths of 490 nm (F490) and 440 nm (F440) and the ratios of F490/F440 that 
correlates with pHi were recorded. At the end of each experiment, a fluorescence ratio-
pHi calibration curve was obtained by using the monovalent cation ionophore nigericin to 
equilibrate H+.  
 
3.3.3 Determination of Cl-/HCO3- exchanger activity 
Cl-/HCO3- exchanger activity of A7r5 cells was assessed by measuring the 
recovery rate of cells from an intracellular alkalinization. Cells grown on coverslips were 
loaded with BCECF as previously described. The coverslips were placed in the chamber 
on the stage of the inverted microscope. They were perfused with HEPES-buffered 
solution. HEPES-buffered solution contained (mM): 150 NaCl, 54 KCl, 2 CaCl2, 1 
MgCl2, 5 HEPES, 10 glucose, adjusted to pH 7.4 with NaOH. To assess CBE activity of 
cells in the presence of H2S, cells were perfused with NaHS-containing HEPES-buffered 
solution, in which 1mM NaHS was added to HEPES-buffered solution, Intracellular 
alkalinization was introduced by rapid addition of 10 mM NH4Cl to bathing solution. 
Exposure of cells to NH4Cl results in diffusion of NH3 across cell membranes, leading to 
rapid intracellular alkalinization (Furtado, 1987). pHi gradually decreases from the peak 
of alkalinization due to efflux of HCO3- via activity of Cl-/HCO3- exchanger, that is, a 
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recovery from alkali load (Xu and Spitzer, 1994; Chiappe de Cingolani et al., 2001). The 
slope of this pHi decrease determines the rate of recovery from the peak of alkalinization 
and is measured in ∆pH/min (Simchowitz and Roos, 1985). After pHi recovered to 
baseline, NH4Cl was washed out by superfusing the chamber with HEPES-buffered 
solution. As aforementioned, at the end of each pHi measurement experiment, a 
fluorescence ratio-pHi calibration curve was obtained by H+ equilibration method using 
nigericin. 
 
3.3.4 Measurement of rat aorta contractility 
All experiments were being approved by the Institutional Animal Care and Use 
Committee (IACUC) of National University of Singapore. Briefly, male SD rats of 6-8 
weeks were anaesthetized with sodium pentobarbital (50mg/kg) via intra-peritoneal (i.p.) 
injection. Thoracic aorta was excised immediately and immersed in Kreb’s bicarbonate 
buffer supplemented with 95% O2/5% CO2. The adherent adipose and connective tissues 
of the aorta were removed, and the aorta was cut into aortic rings of length 2-3 mm and 
mounted in 2.5ml organ baths containing pre-warmed Kreb’s bicarbonate buffer gassed 
with 95% O2/5% CO2, at 37ºC. Changes in tension were recorded using force transducers 
connected to a PowerLab (ADInstruments Inc., Bella Vista, NSW, Australia) running 
Chart v5.1. The rings were stretched passively to a tension of 1.5-2.0 g and allowed to 
equilibrate for one hour before start of experiment. Endothelium was left intact and kept 
undamaged in all experiments. After equilibration, the rings were first pre-contracted 
with submaximal dose of PE (1 µM) before further experiments were commenced. Kreb’s 
bicarbonate buffer of pH 6.6 was prepared by directly adjusting the pH with HCl. Kreb’s 
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bicarbonate buffer containing 60 mM KCl was prepared by equimolar reduction of the 
concentration of NaCl so as to maintain the osmolality of the solution. 
 
3.3.5 Chemicals 
NaHS, 5-(N-Ethyl-N-isopropyl)amiloride (EIPA), 4,4’-Diisothiocyanatostilbene-
2,2’-disulfonic acid disodium salt hydrate (DIDS), cadmium chloride (CdCl2), 
ammonium chloride (NH4Cl), phenylephrine (PE) and nigericin sodium salt were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Glibenclamide was obtained from 
Tocris Bioscience Ltd (UK). BCECF/AM was obtained from Molecular Probes (Eugene, 
OR, USA). EIPA, DIDS, BCECF/AM and glibenclamide were dissolved in DMSO. 
Nigericin sodium salt was dissolved in ethanol. All other chemicals were dissolved in 
water. 
 
3.3.6 Statistical Analysis 
 The data was expressed as mean ± S.E.M. with the number of experimental 
observations indicated in parenthesis. “n” represents number of cells in pHi experiments 
or number of aortic rings in contractility measurement experiments. At least three 
coverslips of cells were used in every group of pHi experiments. Aortic rings were 
obtained from at least two rats in every experiment. Statistical analysis was done by 
ANOVA followed by post hoc Tukey test. A p-value of less than 0.05 was taken to 





3.4.1 Effect of NaHS on pHi in A7r5 cells 
 NaHS has been adopted as a source of H2S in many studies. At 20ºC, one third of 
NaHS will dissociate into HS- and Na+, HS- will eventually react with water to give H2S 
gas (Dombkowski et al., 2004; Abe and Kimura, 1996). Considering the higher accuracy 
of NaHS in terms of concentration issue, NaHS was being used as a source of exogenous 
H2S in this study here. To examine the effect of NaHS on pHi, NaHS was applied to A7r5 
aortic smooth muscle cells. Interestingly, by real-time monitoring of pHi with 
fluorescence probe, direct application of NaHS was found to decrease pHi in a 
concentration-dependent manner ranging from 10 µM to 1 mM (Fig. 15). 10 µM, 100 µM 
and 1 mM NaHS decreased pHi by 0.0859 ± 0.007, 0.1215 ± 0.0134 and 0.1675 ± 0.0066 
respectively. In view of the significant effect of 1 mM NaHS on pHi, this concentration 























Fig. 15. Effect of NaHS on pHi in A7r5 aortic smooth muscle cells. (A) Representative 
tracing showing the effect of 1 mM NaHS; (B) Concentration-dependent effect of NaHS 
on pHi (10 µM NaHS, n=19; 100 µM NaHS, n=25; 1 mM NaHS, n=42). Results shown in 
mean ± S.E., ***p<0.001 compared with pHi before NaHS application.  
 
3.4.2 Effect of NaHS on pHi in A7r5 cells in the presence of a NHE inhibitor 
 NHE expression has been well identified in primary cultured aortic smooth 
muscle cells and A7r5 cell line (Vigne et al., 1988). EIPA is a selective inhibitor of NHE 
and was generally used to inhibit the acid extruder role of NHE. When the cells are being 
pre-incubated with EIPA, NaHS decreased pHi in a similar manner with those without 
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EIPA treatment. No significant change in effect of NaHS on pHi was observed (Fig. 16). 

































Fig. 16. Effect of NaHS on pHi in A7r5 cells in the absence and presence of NHE 
inhibitor. (A) Representative tracings showing the effect of 1 mM NaHS in the absence 
(upper panel) and presence (lower panel) of 10 µM EIPA; (B) Results shown in mean ± 
S.E.M. No statistic difference (n.s.) when compared with NaHS control (n=22). 
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3.4.3 Effect of NaHS on pHi in A7r5 cells in the presence of a Cl-/HCO3- exchanger 
inhibitor 
Cl-/HCO3- exchanger is the main acid loader in vascular smooth muscle cells. The 
role of Cl-/HCO3- exchanger was therefore examined in H2S-induced intracellular 
acidification in A7r5 cells. As shown in Fig. 17, pretreatment with DIDS (1 mM), an 
inhibitor of the Cl-/HCO3- exchanger, significantly attenuated NaHS-induced decrease in 
pHi. These data suggest that NaHS may decrease pHi in A7r5 cells partly by stimulating 
Cl-/HCO3- exchanger. NaHS might activate Cl-/HCO3- exchanger directly or indirectly, 
thus increasing the rate of exchange between Cl- and HCO3-, which eventually lead to a 



































Fig. 17. Effect of NaHS on pHi in A7r5 cells in the absence and presence of Cl-/HCO3- 
exchanger inhibitor. (A) Representative tracings showing the effect of 1 mM NaHS in the 
absence (upper panel) and presence (lower panel) of 1 mM DIDS; (B) Results shown in 





3.4.4 Effect of NaHS on pHi in A7r5 cells in the presence of a plasmalemmal Ca2+-
ATPase inhibitor 
Plasmalemmal Ca2+-ATPases are acid loaders in aortic smooth muscle cells. 
Cadmium at very low concentration (nanomolar) has been shown to inhibit Ca2+-ATPase 
in a specific manner (Akerman et al., 1985; Verbost et al., 1988). 20 nM of CdCl2 was 
being used here to investigate whether Ca2+-ATPase contributed to part of the activity of 
NaHS. As shown in Fig. 18, pretreatment of A7r5 cells with CdCl2 (20nM) for 10 min 



































Fig. 18. Effect of NaHS on pHi in A7r5 cells in the absence and presence of a 
plasmalemmal Ca2+-ATPase inhibitor. (A) Representative tracings showing the effect of 
NaHS and in the absence (upper panel) and presence (lower panel) of 20 nM CdCl2; (B) 





3.4.5 Effect of NaHS on Cl-/HCO3- exchanger activity 
To further confirm the involvement of the Cl-/HCO3- exchanger in the action of 
NaHS, the activity of Cl-/HCO3- exchanger was determined by NH4Cl perfusion. NH4Cl 
perfusion is a widely adopted method to measure the capacity of Cl-/HCO3- exchanger to 
maintain pHi (Xu and Spitzer, 1994; Chiappe de Cingolani et al., 2001). NH4Cl loads the 
cell with alkali, thus causing a significant elevation in pHi. As an acid loader, Cl-/HCO3- 
exchanger activates and extrudes HCO3- in exchange for Cl- which eventually resumes 
the pHi to normal level. Thus, the slope of pHi recovery phase provides a measure of Cl-
/HCO3- exchanger activity (Simchowitz and Roos, 1985). As shown in Fig. 19, NaHS 
































Fig. 19. Effect of NaHS on Cl-/HCO3- exchanger activity. (A) Representative tracings 
showing the initial alkalinization by 10 mM NH4Cl and gradual decrease in pHi which 
signify recovery of cells form alkali load in the absence (upper panel, n=123) and 
presence (lower panel, n=104) of 1 mM NaHS. (E) Results shown in mean ± S.E.M. 
∆pH/min is the rate of recovery from alkali load which correlates with Cl-/HCO3- 
exchanger activity. ***p<0.001 compared with control. 
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3.4.6 Effect of NaHS on rat aorta contractility 
After establishing the effect of NaHS on pHi, it would be essential to investigate its 
physiological relevance. Various studies have reported the spontaneous vasorelaxation 
effect of NaHS on rat aortic ring (Zhao et al., 2001; Zhao and Wang, 2002; Hosoki et al.,  
1997; Ali et al., 2006). Zhao et al. have shown that both NaHS and bubbled H2S solution 
induces vasorelaxation in aortic ring pre-contracted with PE in a dose-dependent fashion. 
With the well profiled properties of H2S in triggering vasorelaxation, the study on pHi 
was extended to measuring vascular ring contractility. As shown in Fig. 20, NaHS at 100 
µM – 10 mM concentration-dependently decreased vascular contractility in the aorta 
rings pre-contracted by PE (0.1 µM) or KCl (60 mM) with EC50 values of 150±20 µM 
and 360±10 µM and Emax values of 28.4 ±10% and 84.4±3.4%. 400 µM NaHS relaxed 
aorta vascular rings pre-contracted by PE or KCl by 28.4% and 86.8% respectively. Thus, 















































Fig. 20. NaHS relaxed rat aorta contractility in a concentration-dependent manner. 
Concentration-dependent effect of NaHS on the contractility of rat aorta pre-contracted 
with 0.1 µM PE (A) or 60 mM KCl (B). *p<0.05, **p<0.01, ***p<0.001 compared with 
the maximal contraction induced by 0.1 µM PE (n=6) or 60 mM KCl (n=8). Results 
shown in mean ± S.E.M.  
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3.4.7 Effect of NaHS on rat aorta contractility in the presence of a NHE inhibitor 
To further exclude the possibility of the involvement of NHE, the effect of EIPA 
on the vasorelaxant effect of NaHS was examined using the aorta rings pre-contracted 
with either PE or KCl. As shown in Fig. 21A and 21B, both PE (0.1 µM) and KCl (60 
mM) markedly increased aortic contractility. EIPA (10µM) did not significantly affect 
the contractile response by either PE or KCl. Application of NaHS relaxed the PE or KCl 
pre-contracted aorta (Fig. 21) to a similar extent to those without EIPA treatment. These 



































































Fig. 21. Effect of NaHS on rat aorta contractility in the absence and presence of a NHE 
inhibitor. (A-B) Representative tracings showing the effect of NaHS on PE (0.1 µM) pre-
contracted ring (A) or KCl (60 mM) pre-contracted ring (B) in the absence and presence 
of EIPA (10 µM); (C-D) Group results showing that EIPA failed to alter the vasorelaxant 
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effect of NaHS on  PE (C) (n=7) or KCl (D) (n=7) pre-contracted aortic ring. *p<0.05 
and ***p<0.001 compared with the contraction by PE or KCl alone, #p<0.05 and 
###p<0.001 compared with the contraction induced by PE or KCl in the presence of 
EIPA. 
 
3.4.8 Effect of NaHS on rat aorta contractility in the presence of a Cl-/HCO3- 
exchanger inhibitor 
As shown above, the Cl-/HCO3- exchanger was responsible for H2S induced 
changes in pHi. whether blockade of Cl-/HCO3- exchanger could also attenuate the 
vasorelaxant effect of H2S was examined with DIDS. As shown in Fig. 22, the 
vasorelaxant effect of H2S was abolished by DIDS. However, it is noteworthy that DIDS 
itself also significantly attenuated PE-induced contraction (Fig. 22A). This is in 
agreement with a previous finding that Cl- currents contribute to the PE-induced 
contraction (Lamb and Barna, 1998). For this reason, the effect of H2S on KCl pre-
contracted aortic rings in the presence and absence of KCl was observed. As shown in 
Fig. 22B, application of NaHS relaxed the ring to approximately 87% of KCl alone. 
DIDS pre-treatment did not affect the contraction caused by KCl but abolished the 
vasorelaxant effect of NaHS. Taken together, the present data suggested that NaHS 




































































Fig. 22. Effect of NaHS on rat aorta contractility in the absence and presence of a Cl-
/HCO3- exchanger inhibitor. (A-B) Representative tracing showing the effect of NaHS on 
PE (0.1 µM) pre-contracted ring (A) or KCl (60 mM) pre-contracted ring (B) in the 
absence and presence of 1 mM DIDS; (C-D) Group results showing that DIDS abolished 
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the vasorelaxant effect of NaHS on PE (C) (n=12) or KCl (D) (n=8) pre-contracted aortic 
rings, *p<0.05, ***p<0.001 compared with the contraction by PE or KCl alone.  
 
 
3.4.9 Effect of NaHS on rat aorta contractility in the presence of a plasmalemmal 
Ca2+-ATPase inhibitor 
Pretreatment of A7r5 cells with CdCl2 (20 nM) for 10 min failed to affect the 
effect of NaHS on pHi. Similarly, CdCl2 also failed to affect the vasorelaxant effect of 
NaHS in either PE or KCl pre-contracted aortic rings (Fig. 23) thereby further confirming 




































































Fig. 23. Effect of NaHS on rat aorta contractility in the absence and presence of a 
plasmalemmal Ca2+-ATPase inhibitor. (A-B) Representative tracings showing the effect 
of NaHS on PE (0.1 µM) pre-contracted ring (A) or KCl (60 mM) pre-contracted ring (B) 
in the absence and presence of 20 nM CdCl2; (C-D) Group results showing that CdCl2 
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failed to alter the vasorelaxant effect of NaHS on PE (C) (n=6) or KCl (D) (n=8) pre-
contracted aortic ring. *p<0.05 and ***p<0.001 compared with the contraction by PE or 
KCl alone, #p<0.05 and ###p<0.001 compared with the contraction induced by PE or 
KCl in the presence of CdCl2. 
 
3.4.10 Role of KATP channels in the vasorelaxation induced by low extracellular pH 
In a pre-contracted vessel, a drop in pHo causes a vasorelaxation. However, 
whether this effect is partly via activation of KATP channels have not been clearly 
established and was still widely debated (Xu et al., 2001). Various studies have 
positioned KATP channels as the main action target for H2S. Incubating the tissue with 10 
µM glibenclamide attenuated the vasorelaxation induced by H2S (Fig. 24), which is 
consistent with various reports by Zhao et al. in 2001. It would be reasonable to raise the 
question whether the pHi –lowering effect of H2S is an independent mechanism which 
does not activate KATP channels or it lies upstream of KATP channel, serving as a 
midstream signal to activate KATP channels.  To examine whether KATP channel is a 
downstream target of the decreased pHi induced by H2S, the relationship between 
decreased pHo and KATP channels have to be first established. In PE-contracted ring, pHo 
of 6.6 relaxed the vessel. However, when 10 µM of glibenclamide was used to inhibit 
KATP channels, no significant change was observed in the vasorelaxation induced by pHo 


































































Fig. 24. Role of KATP channels in the vasorelaxation induced by low extracellular pH. (A) 
Representative tracings showing the effect of NaHS on PE (0.1 µM) pre-contracted ring 
in the absence and presence of 10 µM glibenclamide; (B) Representative tracings 
showing the effect of pHo 6.6 on PE (0.1 µM) pre-contracted ring in the absence and 
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presence of 10 µM glibenclamide; (C-D) Group results showing that glibenclamide partly 
attenuated the vasorelaxant effect of NaHS (C, n=13) but not pHo 6.6 (D, n=8) on pre-
contracted aortic ring. *p<0.05 and ***p<0.001 compared with the contraction by PE 
alone, #p<0.05 and ###p<0.001 compared with the contraction induced by PE in the 
presence of glibenclamide. +<0.05 compared with the relaxation induced by NaHS or pHo 
























pHi regulates many cellular processes, including cell metabolism, Ca2+ 
homeostasis, gene expression, cell motility and contractility, cell-cell coupling, cell 
adhesion and cell death (Puceat, 1999). In vascular smooth muscle cells, a decrease in 
pHi relaxes vascular vessels (Smith et al., 1998). In the present study, whether alterations 
in pHi plays a role in the vasorelaxant effect of H2S in vascular smooth muscle cells was 
investigated. By using real-time direct measurement of pHi, it was found that direct 
application of NaHS causes a decrease in pHi in a concentration-dependent manner 
ranging from 10 µM to 1 mM. 
 
3.5.2 H2S as a weak acid 
However, it is noteworthy that H2S is a weak acid with a pKa value of 7.04 
(Reiffenstein, Hulbert et al. 1992). Upon diffusion into cytosol, it would dissociate into 
HS- and H+. The latter might decrease pHi. Whether the decreased pHi by NaHS is caused 
by the intrinsic chemical property (weak acid) of H2S is a major concern of this study. 
The main key to address this issue relies on whether the buffering capacity of the 
vascular cell could defend against the amount of H+ dissociated from H2S. The highest 
concentration of NaHS used in the present study was 1 mM, which yields approximately 
333 µM of H2S at 20 oC and 185 µM at 37 oC (Dombkowski, Russell et al. 2004). As the 
pHi in vascular smooth muscle cells approximates 7.1 (Smith, Austin et al. 1998), 
according to Henderson-Hasselbalch equation, the concentration of H+ dissociated from 
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H2S   in the cytosol will be about 178 µM (20 oC, pKa 7.04) and 127 µM (37 oC, pKa 
6.755) (Dombkowski, Russell et al. 2004). The buffering capacity assessed by the 
buffering power (β) is largely contributed by intracellular proteins [intrinsic buffering 
power (βi)], and to a lesser extent, by HCO3-/CO2 system. The βi of smooth muscle cell is 
about  41 ± 4 mM/pH unit, which is equivalent to a buffer solution with a  concentration 
of 310 mM and a pKa of 6.0 (Austin and Wray, 1995).  In this case, it requires at least 
5.38 mM of H+ to reduce the pHi by 0.1 in vascular smooth muscle cells. For this reason, 
178 µM H+ dissociated from 1 mM H2S could only decrease pHi from 7.1 to 7.097 
(Appendix 7.1). In other words, with the strong buffering power of vascular smooth 
muscle cells, the decreased pHi from 7.1 to 6.93 ± 0.0066 induced by 1 mM NaHS is 
unlikely to be directly caused by the dissociated H+ from H2S molecules in the cytosol. 
Therefore, H2S may change pHi via modulating the function of pH regulatory 




3.5.3 Mode of activation of Cl-/HCO3- exchanger 
NHE, Cl-/HCO3- exchanger and Ca2+-ATPase are the major transporters 
responsible for regulation of pHi in vascular smooth muscle cells. Blockade or 
stimulation of these transporters would be expected to “dampen” the ability of the cell to 
maintain a normal pHi range. By examining the involvement of these mechanisms, it was 
found that blockade of NHE with EIPA and blockade of Ca2+-ATPase with CdCl2 had no 
effect on the vasorelaxant effect of NaHS, whereas blockade of the Cl-/HCO3- exchanger 
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with DIDS significantly attenuated both the pHi-lowering effect and vasorelaxant effect 
of H2S. Further more, H2S stimulates the activity of Cl-/HCO3- exchanger by 60%. These 
data suggests that H2S may directly or indirectly stimulate Cl-/HCO3- exchanger and 
therefore decrease pHi. Angiotensin II exhibits a similar pHi-lowering effect in cat 
papillary muscles via activation of cardiac Cl-/HCO3- exchanger in a protein kinase C 
(PKC)-dependent manner (Camilion de Hurtado et al., 1998). In addition, various 
potential PKC consensus phosphorylation sites have been identified in the isoforms of 
these exchangers (Yannoukakos et al., 1994). Previous study has shown that H2S triggers 
cardioprotection in a PKC-dependent manner (Bian et al., 2006). In addition, current 
study in my lab has suggested that H2S could stimulate PKC translocation and thus its 
activation (Pan et al., 2007). Besides, studies in renal epithelial cells (Harada et al., 1991), 
hepatocytes (Alvaro et al., 1995) and cardiac cells (Desilets et al., 1994) have shown that 
an increase in cAMP could increase the activity of Cl-/HCO3- exchanger (Puceat, 1999). 
H2S was shown to increase cAMP in neurons (Kimura, 2000). As such, the increased 
activity of Cl-/HCO3- exchanger observed could also be partly dependent on the increased 
production of cAMP by H2S. More studies are warranted to establish the molecular 




3.5.4 Relationship between KATP channels and acidosis 
So what is the relationship between intracellular acidification and opening KATP channels 
and whether H2S -induced intracellular acidification could open KATP channels?  Ishizaka 
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and Kuo found that intracellular acidosis could increase KATP current in vascular smooth 
muscle cells and decrease vascular tone (Ishizaka and Kuo, 1996). In a hypercapnic 
acidosis model, Wang et al. also found that intracellular acidification directly stimulates 
KATP channels and causes vasodilation in mesenteric arteries (Wang et al., 2003). All 
these findings suggest that H2S-induced opening of KATP channels may be, at least 
partially, triggered by intracellular acidification. Acidosis, as occurs in hypoxia, has been 
shown to increase KATP current and decrease tone in vascular smooth muscle cells 
(Ishizaka and Kuo, 1996). However, various discrepancies exist when dealing with the 
effect of pHi alone on KATP channel activity (Xu et al., 2001). In the current set up, the 
vasorelaxation induced by decreased pHo (and thus the subsequent decreased pHi) was 
not affected by inhibition of KATP channels with glibenclamide. This ruled out the 
possibility that a decrease in pHi can concurrently activate KATP channels besides its 
effect on Ca2+-activated contractions etc. As such, this independent relationship indirectly 
negated the intermediary role of pHi between H2S and KATP channels. In other words, 
H2S exerts its vasorelaxation by parallel activation KATP channels and activation of Cl-
/HCO3- exchanger to decrease pHi. However, several pitfalls may exist in this 
experimental setup which could give rise to the controversial result, one would be the 
inability to measure and thus control the exact change pHi induced by pHo 6.6. As such, 
more precise experiments are required to further reveal the relationship between 





3.5.5 Conclusion and significance 
In summary, in the present study it was demonstrated for the first time that NaHS 
decreased pHi ranging from a concentration as low as 10 µM to 1 mM, which yields to 
approximately 3 - 333 µM H2S. This wide range of concentration proposed both an 
intrinsic role for endogenous H2S to regulate pHi at physiological condition and an 
additional role for exogenous H2S to alter pHi. As a vasodilator, H2S may therefore 
relaxes smooth muscle may not only through activation of KATP channels but also 
through decreasing pHi via regulating and enhancing the activity of an important acid 
loader, Cl-/HCO3- exchanger in smooth muscle cells. The present study added a brand 
new line to the study on the action of H2S. A change in pHi may have a big impact on 
various physiological functions e.g. regulation of cell volume in the brain cells. Unveiling 
the effects of H2S on pHi regulation would serve as an important progression to add extra 
significance to the physiological role of H2S in various biological systems as a 
gasotransmitter.  
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ROLE OF HYDROGEN SULPHIDE IN  






4.1.1 Overview on ischemic preconditioning 
 Ever since its discovery in 1986 by Murry et al., ischemic preconditioning (IP) 
has been positioned as one of the most potent cardioprotective mechanism (Murry et al., 
1986) in line with ischemic postconditioning which was later introduced in 2003 by Zhao 
and his colleagues (Zhao et al., 2003). In brief, IP refers to the phenomenon whereby 
brief periods of sublethal ischemic episodes protect the tissue from subsequent more 
severe ischemia-reperfusion insults (Eisen et al., 2004). In the heart, this phenomenon is 
of therapeutic importance considering the high mortality and morbidity of ischemic heart 
diseases. The protective effect of IP in the heart is manifested in vivo and ex vivo by a 
reduction in infarct size, restoration of cardiac pump function and alleviation of 
ventricular arrhythmia, and in vitro by improving cardiac myocyte contractility and 
reducing rates of cell necrosis and apoptosis (Eisen et al., 2004). Despite twenty years of 
research into the field of ischemic preconditioning, the actual mechanism of protection 
remains unclear (Hausenloy and Yellon, 2006). Various signaling-transduction pathways 
have been identified as mediators of IP. PKC and KATP channels have gained much 
attention to serve as the central mediator of IP although KATP channel was also shown to 
play certain role as a trigger as well as an end-effector (reviewed by Oldenburg et al., 
2002; Yellon and Downey, 2003). Recently, much progress has been made in elucidating 
the signal transduction pathways that convey the extracellular signal initiated by the 
preconditioning stimulus to the intracellular targets of cardioprotection, with many of 
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these pathways involving the activation of a diverse array of survival protein kinase 
cascades. Among the known cell survival pathways, the mitogen-activated protein kinase 
ERK1/2 and PI3K/Akt pathway has received a considerable amount of importance 
(Hausenloy and Yellon, 2006). 
 
4.1.2 Overview on ischemic postconditioning 
 Despite the promising cardioprotective effect of IP, it has a major limitation in 
that brief ischemia maneuver or its mimetic which can trigger pharmacological 
preconditioning has to be applied before the index ischemia insult. In the event where 
myocardial infarction was unpredictable, the application of preconditioning treatment 
would not be feasible. This has lead to the introduction of the concept: ischemic 
postconditioning by Vinten-Johansen’s group in 2002 (Baxter and Yellon, 2003). 
Ischemic postconditioning (IPostC) is defined as the phenomenon where rapid 
intermittent interruptions of blood flow in the early phase of reperfusion resulted to a 
reduced myocardial injury (Zhao and Vinten-Johansen, 2006). This maneuver has 
produced promising protection against ischemia-reperfusion injury in mice (Kin et al., 
2005), rats (Kin et al., 2004), rabbits (Yang et al., 2004c), dogs (Zhao et al., 2003) and in 
human patients (Staat et al., 2005). 
 
4.1.3 Lethal reperfusion injury 
The cardioprotective effect of IPostC was closely linked to a phenomenon termed 
lethal reperfusion injury. Reperfusion injury arise when sudden reperfusion was 
introduced after a prolong period of ischemia. A sudden reflow of blood into the heart 
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results to an abrupt change in the vascular environment which induces detrimental events 
such as sudden increase in reactive oxygen species (ROS) production (Grill et al., 1992), 
intracellular Ca2+ overload (Sun et al., 2005), opening of mitochondrial permeability 
transition pore (Halestrap et al., 2004) (Piper et al., 1998), contracture and neutrophil 
activation (Vinten-Johansen, 2004) etc. This subsequently leads to endothelial and 
vascular dysfunction, metabolic dysfunction, contractile dysfunction, dysrhythmias and 
eventually myocytes necrosis and apoptosis (Zhao and Vinten-Johansen, 2006).  
 
4.1.4 Mechanisms of actions of IPostC 
The main purpose of introducing shuttering during initial reperfusion phase is to 
disrupt the process of lethal reperfusion injury. The mechanism of the cardioprotective 


















































Fig. 25. Hypothetical scheme showing the possible mechanisms of protection induced by 
IPostC. The mechanisms of action were divided into 3 components: mechanical (passive 
arm), cellular (passive arm) and molecular (active arm). Mechanical events resulted in (i) 
water extravasations which causes edema and cell swelling; (ii) delayed washout of 
adenosine released from endothelial cells which attenuates the superoxide anion 
generation from neutrophils and endothelial cells; and (iii) activation of KATP channels 
via adenosinergic G-protein coupled receptor (GPCR). Cellular events includes better 
reservation of endothelial cells which generates protective NO. Molecular events include 
activation of pro-survival kinases and activation of KATP channels. Ado, adenosine; CM, 
cardiac myocytes; EC, endothelial cells; GPCR, G-protein coupled receptor; IPostC, 
ischemic postconditioning; mPTP, mitochondria permeability transition pore; NO, nitric 
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oxide; O2•, superoxide anion; PMN, polymorphonuclear leukocytes. (+): action/process 
promoted by IPostC intervention; (-) action/ process inhibited by IPostC intervention. 
 
The passive arm of IPostC constitutes mechanical events and cellular events 
(Vinten-Johansen et al., 2005). The mechanical events are directly attributed by episodes 
of ischemia/reperfusion during early reperfusion phase which interrupt the sudden onset 
of full flow reperfusion responsible for lethal reperfusion injury. As such, the heart is 
protected “mechanically” by (1) negative modulation of coronary perfusion pressure 
which would potentially mitigate the Starling forces favoring the movement of 
intravascular water towards the interstitial space, which successively causes cell swelling 
and edema; (2) limitation of oxygen which is a precursor of ROS; and (3) delay in 
alkalinization of myocardial pHi by attenuating washout of protons from extracellular 
space (Vinten-Johansen et al., 2005). In contrast, the cellular events involve the increased 
NO release due to better endothelial cell survival and preservation of their functions, 
which further attenuates superoxide anion level and both neutrophil activation and 
adherence to endothelial cells (Vinten-Johansen et al., 2005).  
In addition to the passive arm which would be well anticipated due to interrupted 
reperfusion, IPostC treatment activates the reperfusion injury salvage kinase (RISK) 
pathway. This pathway includes several anti-apoptotic pro-survival signaling kinases 
(PI3K/Akt, mammalian target of rapamycin [mTOR], p70S6 kinase, glycogen synthase 
kinase 3β [GSK3β], ERK 1/2), KATP channels, and the mitochondrial permeability 
transition pore (mPTP), which may serve as a major convergence point that determines 
whether a cell survives or not (Gross and Auchampach, 2007). Activation of several 
members of this pathway and other pro-survival kinases such as Akt (Tsang et al., 2004; 
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Zhu et al., 2006), PKC (Zatta et al., 2006; Philipp et al., 2006), ERK1/2 (Darling et al., 
2005) and inhibition of JNK and p38 MAP Kinase (Sun et al., 2006) have been shown. 
Stimulation of these survival kinases in turn activate their downstream effectors such as 
the opening of KATP channels, inhibition of mitochondria transition pore (Argaud et al., 
2005) etc. These molecular events constitute the active arm of IPostC. 
 
4.1.5 Cardioprotective effect of H2S 
In the cardiovascular system, H2S was mainly generated by CSE endogenously. 
CSE activity has been detected in vascular smooth muscle (Zhao et al., 2001) and the 
heart (Geng et al., 2004). In addition, approximately 46 µM H2S was detected in rat 
serum (Zhao et al., 2001) whereas approximately 52 µM H2S was detected in human 
serum (Jiang et al., 2005). As such, the heart was constantly bathed in a considerable 
amount of H2S generated by the cardiac myocytes locally and from the blood. 
Interestingly, several studies have suggested a correlation between CSE activity, H2S 
concentration and myocardial injury. In human patients, it was reported that plasma H2S 
concentration was significantly lower in patients with coronary heart disease (Jiang et al., 
2005). Besides, it was reported that the concentration of endogenous H2S in plasma and 
myocardial tissue was significantly decreased in isoproterenol-induced myocardial injury 
(Geng et al., 2004). In addition, the concentration of H2S detected in the medium of 
freshly isolated cardiac myocytes was decreased upon ischemia treatment (Bian et al., 
2006). Taken together, the common accepted trend is that the level of endogenous H2S 
was tightly regulated in the heart and ischemia could induce a significant change in the 
production of endogenous H2S by CSE. 
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H2S have been shown to protect the heart from myocardial ischemia-reperfusion 
in various studies (Johansen et al., 2006; Zhu et al., 2007; Sivarajah et al., 2006). More 
importantly, recent work has shown that H2S preconditioning (SP) produced cardiac 
protective effects similar to that induced by IP (Pan et al., 2006; Bian et al., 2006). SP 
was shown to improve cardiac myocytes viability, preserve Ca2+ handling after ischemia 
insult and anti-arrhythmic. The underlying mechanism(s) may involve NO release, KATP 
channel opening (Pan et al., 2006) and activation of PKC. In addition, endogenous H2S 
contributes to IP-induced cardioprotection (Bian et al., 2006; Pan et al., 2006). 
 In addition, as discussed in section 1.5.2, H2S was shown to trigger activation of 
one of the member of MAP kinase, ERK in various vascular smooth muscle cells, 
macrophages and monocytes. ERK is a member of the RISK pathway and activation of 
ERK during reperfusion has been shown to confer strong protective effect on the heart. 
More importantly, studies in my lab has revealed that the protective effect of H2S 
postconditioning was dependent on activation of ERK1/2, Akt (Hu et al., 2007) and PKC 





4.2 Hypothesis and Objectives 
Although the complete cardioprotective mechanisms of H2S remains to be 
clarified, the general understanding on H2S up to date has led to the hypothesis that 
endogenous H2S may contribute to IPostC based on two lines of evidences: (1) H2S is a 
potent opener of KATP channels (Zhao et al., 2001; Tang et al., 2005; Yang et al., 2005; 
Penna et al., 2007), which is one of the downstream target of IPostC (Yang et al., 2004; 
Mykytenko et al., 2005; Yang et al., 2003); (2) exogenous H2S activates several pro-
survival kinases such as ERK1/2 (Zhi et al., 2007; Yang et al., 2004; Yang et al., 2006), 
Akt (Hu et al., 2007) and PKC (Pan et al., 2007) which consists of the active arm of 
IPostC. As such, the aim of the current study is to examine whether endogenous H2S 
plays a role in mediating the active arm of IPostC’s via activation of pro-survival kinases. 
In addition, the effect of exogenous H2S to serve as a potential candidate to trigger 












4.3 Materials and methods 
The study protocol was approved by the Institutional Animal Care and Use 
Committees (IACUC) of National University of Singapore. 
 
4.3.1 Isolated rat heart perfusion model 
Adult male Sprague-Dawley rats (8 weeks, 200-250 g) were anesthetized by i.p 
administration of pentobarbital (60 mg/kg). Heparin (1000 IU) was administered i.p. to 
prevent coagulation during removal of the heart. A central thoractotomy was performed 
and the heart was rapidly excised and placed in ice cold buffer. The heart was mounted 
onto a Langendorff apparatus via aortic root and perfused with modified Krebs 
bicarbonate buffer containing (mM) 118 NaCl, 5.4 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 
CaCl2, 25 NaHCO3 and 11 glucose, pH 7.4 at 37 °C. 
Electrocardiogram (ECG) of the isolated heart was monitored and recorded with 
two electrodes hooked to the apex and the aorta respectively as described previously 
(Bian et al., 2006). Isolated hearts were allowed to stabilize for 10 min. Any heart that 
exhibited arrhythmia during this period was discarded. Isolated rat hearts with normal 
ECGs were randomly assigned to the experiment groups. 
 
4.3.2  Measurement of cardiodynamic functions 
Cardiodynamic parameters were measured with a pressure transducer connected to a 
PowerLab system (ADInstruments, Australia).  An incision was made in the left atrium 
and a fluid-filled latex balloon connected to the pressure transducer was inserted and 
positioned in the left ventricular cavity for continuous assessment of cardiodynamic 
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function. The balloon was initially inflated to an end-diastolic pressure of 5 – 10 mmHg 
and thereafter the balloon volume was held constant.  The hearts were perfused at a 
constant flow rate of 12 ml/min. Cardiodynamic data were analyzed using a Data 
Acquisition System (PowerLab System, AD Instruments, Australia). Left ventricular end 
diastolic pressure (LVeDP) was represented by the minimum pressure recorded during 
diastoles, left ventricular developed pressure (LVDP) was calculated as the difference 
between left ventricular systolic pressure and left ventricular diastolic pressure, 
contractility (+dP/dt) was represented by the maximum gradient during systoles and 
compliance (-dP/dt) was represented by the minimum gradient during diastoles.  
 
4.3.3  Experimental Protocol 
Isolated rat hearts were perfused and stabilized for at least 20 minutes before data 
recording. Global ischemia was mimicked by stopping the perfusion of Krebs bicarbonate 
buffer, i.e. perfusion rate = 0 ml/min. The hearts were randomly divided into nine groups 
according to the perfusion protocol as shown in Fig. 26A, 29A, 32A and 33A. Vehicle 
postconditioning group (VPostC) and ischemic postconditioning group (IPostC) serve as 
the negative and positive controls in this study. In VPostC and IPostC groups, hearts 
experienced 20 min equilibration followed by 40 minutes global ischemia. Upon 
reperfusion, IPostC hearts were treated with 6 cycles of 10 s reperfusion and 10 s no flow 
ischemia (total intervention time of 2 min) whereas VPostC hearts did not receive any 
additional treatment. In PAG group, hearts were pre-treated with 2mM PAG for 15 min 
prior ischemia up to 2 min after postconditioning treatment (Fig. 26A). Two protocols of 
H2S postconditioning were adopted: SPostC group hearts were treated with 6 cycles of 10 
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s reperfusion and 10 s 100 µM NaHS intermittently whereas SPostC2 group hearts were 
treated with 100µM NaHS for two minutes continuously (Fig. 29A). In four parallel 
groups (SPostC-LY, SPostC2-LY, SPostC-CHE and SPostC2-CHE), hearts were treated 
with 15 µM LY294002 or 10 µM chelerythrine 10 min before, during and 5 min after 
ischemia insults (Fig. 32A & 33A).  
 
4.3.4  Western blot analysis 
After 1 hr reperfusion, the ventricular tissues of the heart were freeze-clamped in liquid 
nitrogen and stored at -80ºC for further analysis. Phosphorylation state of Akt and 
translocation of PKCε was assessed with standard western immunoblotting. Briefly, 25 
mg of tissues were minced and homogenized in ice-cold lysis buffer containing (mM) 25 
Tris·HCl pH 7.5, 150 NaCl, 5 EDTA, 10 NaF, 1 Na3VO4, 1% NP-40 and 0.4% 
deoxycholic acid supplemented with protease inhibitor cocktail tablet (Roche Diagnostics, 
Penzberg, Germany). Homogenates were centrifuged at 1,000g for 10 min. The cytosolic 
fraction of the proteins were obtained by collecting the supernatant and centrifuged at 
16,000g to maximize protein extraction. The membrane fraction was obtained by treating 
the pellet with lysis buffer supplemented with 1% Triton-X followed by centrifugation at 
16,000g. Protein concentrations were determined using the modified Lowry method. 
Proteins were denatured with SDS-sample buffer and epitopes were exposed by boiling 
the protein samples at 100 oC for 5 min. Equal amount of proteins were loaded and 
separated by electrophoresis on 12% SDS-polyacrylamide gel and transferred to 
nitrocellulose membrane. The membrane was first probed with the primary antibody that 
recognizes phospho-Akt (p-Akt), total Akt, or PKCε and then with a horseradish 
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peroxidase-conjugated goat-anti-rabbit IgG secondary antibody. Immunoreactivity was 
detected using the enhanced chemiluminescence method. Protein levels were normalized 
to the VPostC group. 
 
4.3.5  Chemicals 
NaHS and PAG were purchased from Sigma Chemical Co, USA. Chelerythrine 
chloride and LY294002 were purchased from Calbiochem, Darmstadt, Germany. 
Polyclonal anti-phospho-Akt rabbit IgG and polyclonal anti-total-Akt rabbit IgG were 
purchased from Cell Signaling Technology Inc, USA. Polyclonal anti-PKCε rabbit IgG 
antibody was purchased from Santa Cruz Biotechnology, Santa Cruz, CA. Chelerythrine 
chloride and LY294002 was dissolved in DMSO and added to the Krebs bicarbonate 
buffer such that the final DMSO concentration was less than 0.1%. All other chemicals 
were dissolved in deionized water.  
As used in numerous publications, NaHS, a donor of H2S, was employed in these 
experiments as its use allows for a better determination of the concentration of H2S in 
solution than bubbling H2S gas. NaHS dissociates to Na+ and HS- in solution. Thereafter 
HS- associates with H+ and produces H2S. Approximately one-third of the H2S in aqueous 
solution exists in the undissociated form (H2S) at 20ºC (Abe and Kimura, 1996). At 37ºC, 
the undissociated form of H2S is around 18.5% i.e. approximately 18.5 µM (Dombkowski 
et al., 2004), which is well within the range of physiological concentrations in rat plasma 




4.3.6  Statistical analysis 
All values were expressed as mean ± SEM. Cardiodynamic data were assessed 
with ANOVA followed by Tukey’s post hoc test. Immunoreactivity of each protein of 
interest was normalized to VPostC and compared among the groups by ANOVA and 
subsequent Newman-Keuls post hoc test. Differences were considered statistically 





















4.4.1 Role of endogenous H2S on the cardioprotective effect of IPostC 
The role of endogenous H2S in the cardioprotection afforded by IPostC was 
examined by using an irreversible inhibitor of CSE, PAG, to eliminate the endogenous 
production of H2S from the heart. The experimental design was shown in Fig. 26 A and 
described in Materials and Methods. As shown in Fig. 26B and 26C, IPostC significantly 
protected the heart by resuming the functional performance after ischemia as compared to 
VPostC when assessed with LVeDP, LVDP, +dP/dt and -dP/dt. Inhibition of endogenous 
H2S synthesis with 2 mM PAG from 15 minutes before ischemia up to 2 minutes after 
reperfusion significantly diminished the cardioprotective effect of IPostC by having an 
elevated LVeDP, reduced LVDP and +dP/dt (Fig. 26C). However, no significant change 






































6 cycles of 10s I/R
2 mM PAG
6 cycles of 10s I/R
20’ 40’ 60’

































































20 40 60 80 100 120
Time (min)
20 40 60 80 100 120
Time (min)
20 40 60 80 100 120
Time (min)











































# # # #
*




Fig. 26. Effect of IPostC on cardiodynamics with and without inhibition of H2S synthesis. 
(A) Experimental protocols: Vehicle postconditioning (VPostC) (), ischemic 
postconditioning (IPostC) () and IPostC in the presence of H2S synthesis inhibitor, 
2mM PAG (PAG) (); (B) Representative tracings showing the mechanical performance 
of isolated rat hearts during and after 40 minutes ischemia in different groups. Records 
show left ventricular developed pressure (LVDP); (C) Cardiodynamic parameters, upper 
left panel: LVeDP, upper right panel, LVDP, lower left panel, +dP/dt and lower right 
panel, -dP/dt. All values are mean ± S.E.M. (n=6), *p<0.05 VPostC vs. IPostC, #p<0.05 
IPostC vs. PAG.    
 
4.4.2 Effect of H2S synthesis inhibition on the activation of Akt and PKC triggered 
by IPostC 
Since IPostC was shown to trigger cardioprotection partly via activation of pro-
survival kinase, Akt (Tsang et al., 2004; Zhu et al., 2006), Akt phosphorylation induced 
by IPostC treatment was examined. As shown in Fig. 27A, IPostC significantly induced 
phosphorylation of Akt at the end of 1hr reperfusion. This is in consistent with the 
previous findings from other groups (Tsang et al., 2004; Zhu et al., 2006). However, 
inhibition of H2S synthesis with PAG failed to attenuate SPostC-induced Akt 



































Fig. 27. Activation of Akt by IPostC with and without inhibition of H2S synthesis. (A) 
representative blot of Akt phosphorylation; (B) results shown in mean ± S.E.M. The 
phosphorylation status of Akt was depicted as the ratio of phospho-Akt (p-Akt) to total 
Akt. Ratios are normalized to VPostC values (n=3).  *p<0.05 VpostC vs. IPostC, #p<0.05 
IPostC vs. PAG.    
 
4.4.3 Effect of H2S synthesis inhibition on the activation of PKCε triggered by 
IPostC 
Besides Akt, PKC activation is another important trigger/mediator in the 
cardioprotection induced by IPostC (Zatta et al., 2006; Philipp et al., 2006). As shown in 
Fig. 28B, an increase in the fraction of PKCε translocated from cytosol to membrane was 
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observed after IPostC treatment followed by 1hr reperfusion which suggests an activation 
of PKCε. Inhibition of endogenous H2S synthesis with PAG significantly reversed the 
translocation of PKCε as assessed by the ratio of PKCε detected in the membrane and 
cytosolic fraction (Fig. 28B). This suggested a role for endogenous H2S on PKCε 





































Fig 28. Activation of PKC by IPostC with and without inhibition of H2S synthesis. (A) 
Upper panel, representative blot of PKCε translocation;(B) results shown in mean ± 
S.E.M. The activation of PKCε was depicted as the ratio of translocated membrane PKCε 
to cytosolic PKCε. Ratios are normalized to VPostC values (n=3). *p<0.05 VPostC vs. 
IPostC, #p<0.05 IPostC vs. PAG.    
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4.4.4 H2S postconditioning improves the cardiodynamic performance of isolated 
perfused rat heart after ischemia 
In order to assess whether exogenous H2S is a potential candidate for pharmacological 
postconditioning, NaHS-reperfusion was used to substitute the six episodes of ischemia-
reperfusion to produce H2S postconditioning. Two protocols of H2S postconditioning 
were being adopted: namely SPostC, with 6 cycles of 10 s reperfusion and 10 s 100 µM 
NaHS after ischemia; and SPostC2 with 100 µM NaHS for two minutes continuously, 
which is the adapted protocol for pharmacological postconditioning generally adopted by 
other groups (Lu et al., 2006; Tissier et al., 2007) (Fig. 29A). As shown in Fig. 29B and 
29C, SPostC and SPostC2 treatment significantly improved the cardiodynamics during 
reperfusion after ischemia when assessed via LVeDP, LVDP, +dP/dt and –dP/dt. The 
cardioprotective effect was comparable to that of IPostC. This positioned H2S as a 
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Fig. 29. Effect of H2S postconditioning on cardiodynamics. (A) Experimental protocols: 
VPostC (), IPostC (), H2S postconditioning with 6 cycles of 10 s reperfusion and 10 s 
100 µM NaHS intermittently (SPostC) () and H2S postconditioning with 100 µM NaHS 
for two minutes continuously (SPostC2) (); (B) Representative tracings showing the 
mechanical performance of isolated rat hearts during and after 40 minutes ischemia in 
different groups. Records show left ventricular developed pressure (LVDP); (C) 
Cardiodynamic parameters, upper left panel: LVeDP, upper right panel, LVDP, lower left 
panel, +dP/dt and lower right panel, -dP/dt. All values are mean ± S.E.M. (n=6), *p<0.05 



















4.4.5 H2S postconditioning involves activation of Akt  
To determine the molecular mechanisms involved in the cardioprotection triggered by 
both protocols of H2S postconditioning, the activation of Akt and PKCε was determined. 
When compared to VPostC, both SPostC and SPostC2 treatment induced significant 




































Fig. 30. Activation of Akt by H2S postconditioning. (A) representative blot of Akt 
phosphorylation; (B) results shown in mean ± S.E.M. The phosphorylation of Akt was 
depicted as the ratio of p-Akt to total Akt. Ratios are normalized to VPostC values (n=3). 
*p<0.05 vs. VPostC.      
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4.4.6 H2S postconditioning involves activation of PKCε 
Interestingly, SPostC, but not SPostC2, induced the translocation of PKCε from cytosol 
to membrane. This implied that SPostC and SPostC2 may induce cardioprotection via 





































Fig. 31. Activation of PKCε by H2S postconditioning. (A) representative blot of PKCε 
translocation status; (B) results shown in mean ± S.E.M. The activation status of PKCε 
was depicted as the ratio of translocated membrane PKCε to cytosolic PKCε. Ratios are 
normalized to VPostC values (n=3). *p<0.05 vs. VPostC.    
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4.4.7 Roles of Akt and PKCε in the cardioprotection triggered by H2S 
postconditioning – intermittent protocol (SPostC) 
To further confirm the role of Akt and PKCε in H2S postconditioning, specific inhibitors 
of PI3K and PKC were administered in both SPostC and SPostC2 groups. In SPostC 
groups, inhibition of either PI3K/Akt pathway with 15 µM LY294002 or PKC with 10 
µM chelerythrine during the H2S infusion period significantly reversed the protective 
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Fig. 32. Effect of SPostC on cardiodynamics with and without Akt or PKC inhibition. (A) 
Experimental protocols: H2S postconditioning with 6 cycles of 10 s reperfusion and 10 s 
100 µM NaHS intermittently (SPostC) (), SPostC in the presence of 15 µM LY294002 
(SPostC-LY) () and SPostC in the presence of 10 µM chelerythrine (SPostC-CHE) (); 
(B) Cardiodynamic parameters, upper left panel: LVeDP, upper right panel, LVDP, lower 
left panel, +dP/dt and lower right panel, -dP/dt. All values are mean ± S.E.M. (n=5-6), 
*p<0.05 SPostC vs. SPostC-LY, #p<0.05 SPostC vs. SPostC-CHE.    
 
 
4.4.8 Roles of Akt and PKCε in the cardioprotection triggered by H2S 
postconditioning – continuous protocol (SPostC2) 
 In SPostC2 groups, 15 µM LY294002 partly abolished the cardioprotective as 
expected (Fig. 33). On the other hand, despite the absence of PKCε activation by 
SPostC2 treatment at 1 hour reperfusion, inhibition of PKC by 10 µM chelerythrine 
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Fig. 33. Effect of SPostC2 on cardiodynamics with and without Akt or PKC inhibition. 
(A) Experimental protocols: H2S postconditioning 100µM NaHS for two minutes 
continuously (SPostC2) (), SPostC2 in the presence of 15 µM LY294002 (SPostC2-LY) 
() and SPostC2 in the presence of 10 µM chelerythrine (SPostC2-CHE) (); (B) 
Cardiodynamic parameters: upper left panel, LVeDP, upper right panel, LVDP, lower left 
panel, +dP/dt and lower right panel, -dP/dt. All values are mean ± S.E.M. (n=5-6), 




















4.5.1 Summary on the role of endogenous H2S on the cardioprotective effect of 
IPostC 
The main objective of this study is to unveil the role of endogenous H2S in IPostC 
and to explore the feasibility of exogenous H2S administration to act as a trigger for 
pharmacological postconditioning. Cardiodynamics of isolated perfused rat heart was 
chosen as a parameter to assess the functional performance of the heart after ischemia. 
The present study showed that IPostC significantly improved the heart contractile 
function during ischemia-reperfusion. This is in consistent with previous findings that 
IPostC protects the heart from lethal ischemia reperfusion injury when assessed by 
infarction size (Kin et al., 2004; Yang et al., 2005; Darling et al., 2005), cardiodynamic 
performance (Kin et al., 2005; Crisostomo et al., 2006; Zhu et al., 2006; Fantinelli and 
Mosca, 2007), cellular injury index (Wang et al., 2006; Sun et al., 2005) etc. in the 
cardioprotection of IPostC. Inhibition of endogenous H2S synthesis with PAG, an 
irreversible inhibitor of CSE, partly attenuated the cardioprotective effect of IPostC, 
suggesting a role for endogenous H2S in the phenomenon.  Interestingly, inhibition of 
endogenous H2S synthesis with PAG attenuated the translocation of PKCε induced by 
IPostC. This data suggest a central dominant role for endogenous H2S in the activation of 
the pro-survival PKCε. In contrast, the activation of Akt by IPostC might not be solely 
dependent on endogenous H2S since PAG failed to affect the phosphorylation of Akt. 
Adenosine receptor activation (Philipp et al., 2006) and prolonged transient acidosis 
(Fujita et al., 2007) during IPostC has been shown to be able to induce Akt 
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phosphorylation. These signaling mechanisms may act in a concerted manner to trigger 
Akt activation.  
 
4.5.2 Level of endogenous H2S during IPostC  
During postconditioning, interruption of the reflow at early reperfusion not only 
decelerate the sudden burst of ROS and Ca2+ overload, but also initiates the generation of 
endogenous autocoids such as adenosines (Kin et al., 2005), bradykinins (BK) (Penna et 
al., 2007). In view of the increased release of autocoids and the central role played by NO 
in the downstream signaling mechanisms of IPostC, the synthesis of endogenous H2S 
might also be up-regulated by IPostC maneuver. It was reported that the concentration of 
H2S was significantly decreased the initial phase of reperfusion after ischemia/ or 
myocardial injury (Bian et al., 2006; Geng et al., 2004). As such, the concentration of 
H2S may be down-regulated during ischemia due to reduced level of PLP (Kelly et al., 
2004), which is a cofactor of CSE. A decreased level of cardioprotective endogenous H2S 
during ischemia could have resulted to an increased damage to the myocardial tissue. 
Therefore, it would be logical to anticipate that IPostC treatment was able to stimulate the 
activity of CSE, thus causing an increase in the local concentration of the 
cardioprotective H2S. PLP level in the heart could also be resumed during reperfusion, 
which could stimulate the subsequent synthesis of H2S immediately. More importantly, 
with the application of the postconditioning maneuver, the H2S synthesized may be 
retained and accumulate in the heart in an intermittent manner, which mimics the 
scenario of kinin accumulation as proposed by Penna et al. (Penna et al., 2007). IPostC 
with intermittent interruption on reperfusion might have triggered pathways leading to a 
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stronger protective state via accumulation of different signaling players such as BK 
(Penna et al., 2007), adenosine and H2S rather than pure reperfusion which resulted to 
continuous wash away of PLP and thus H2S.  Interestingly, the effect of H2S synthesis 
inhibition on the impaired cardiac function was most significant at the early stage of 
reperfusion. This inhibitory effect on IPostC gradually diminished along the reperfusion 
stage when assessed with LVeDP and +dP/dt, further supporting the hypothesis that the 
H2S synthesis may be up-regulated at the initial phase of reperfusion specifically by 
IPostC interruptions. 
 
4.5.3 Role of endogenous H2S on activation of Akt and PKCε 
Interestingly, inhibition of endogenous H2S synthesis with PAG attenuated the 
translocation of PKCε induced by IPostC. This data suggest a central dominant role for 
endogenous H2S in the activation of the pro-survival PKCε. In contrast, the activation of 
Akt by IPostC might not be solely dependent on endogenous H2S since PAG failed to 
affect the phosphorylation of Akt. Adenosine receptor activation (Philipp et al., 2006) 
and prolonged transient acidosis during IPostC has been shown to be able to induce Akt 
phosphorylation. These signaling mechanisms may act in a concerted manner to trigger 
Akt activation.  
 
4.5.4 Summary on the cardioprotective effect of H2S postconditioning 
Two IPostC protocols commonly used by other groups (Lu et al., 2006; Tissier et 
al., 2007) were employed to investigate whether postconditioning with exogenous H2S 
can also produce cardioprotection. Both protocols of H2S postconditioning produced 
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significant and similar cardioprotective effect, supporting the previous studies that H2S 
possesses a general cardioprotective role. Interestingly, both protocols initiated an 
activation of Akt whereas only the six intermittent administration of H2S protocol was 
able to cause an increase in PKCε activation. Continuous infusion of H2S for two minutes 
failed to initiate PKCε translocation. This suggests that a stronger stimulation against 
PKCε translocation could have been initiated by intermittent H2S infusion in contrast to 
continuous administration of H2S for two minutes. A similar circumstance was observed 
in a study on BK B2 receptors where continuous infusion of BK for three minutes failed 
to trigger IPostC protection while administration of intermittent BK achieved a strong 
protective effect against ischemia-reperfusion induced infarction (Penna et al., 2007).  
 
 
4.5.5 Activation of Akt and PKCε by H2S postconditioning 
 The roles of Akt and PKCε were further confirmed by inhibiting the hearts with 
specific inhibitors of PI3K and PKC. In SPostC and SPostC2 groups, inhibition of either 
PI3K/Akt or PKC during the H2S infusion significantly abolished the cardioprotective 
effect of both SPostC and SPostC2. These data clearly suggest that activation of both Akt 
and PKC mediate the cardioprotection of SPostC and SPostC2. Interestingly, western blot 
analysis showed that SPostC2 treatment failed to stimulate PKCε after one hour 
reperfusion despite blockade of PKC with chelerythrine attenuated the cardioprotection 
of SPostC2. Several possible mechanisms could be involved. One possibility is that 
SPostC2 stimulates other PKC isoforms. The PKC family consists of at least 10 isoforms, 
among which PKC-α, ε and δ are the prominent isoforms expressed in the heart (Mackay 
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et al., 2001). The involvement of PKC-α and δ needs to be examined. The other 
possibility is that the signal generated by SPostC2 was not as strong as that induced by 
SPostC as discussed earlier. As a result, the duration of PKC activation may not sustained 
until the end of one hour reperfusion in which the hearts were harvested. Moreover, there 
are some evidences which indicate that the PKC translocation triggered by ischemic 
preconditioning treatment was transient rather than sustained (Simonis et al., 2003), 
Although PKCε translocation was still detected after one hour reperfusion in most of the 
current IPostC protocols, the exact time course of PKCε is still unknown. Therefore, 
more experiments are warranted to examine the involvement of other PKC isoforms and 
the time course of the activation of PKCε. 
 
 
4.5.6 KATP channels in H2S postconditioning 
Although in the present study, the cardioprotection induced by IPostC and SPostC 
was shown to involve Akt and PKC pathway, the effectors of this postconditioning is still 
unknown. There is a general trend which suggests that mitochondrial KATP channel 
opening is one of the downstream effectors of IPostC (Yang et al., 2004; Penna et al., 
2007). Previous studies have shown that blockade of KATP channels attenuated the 
protective effect of H2S preconditioning (Bian et al., 2006; Pan et al., 2006). More 
importantly, H2S was shown to be a direct KATP channel opener in vascular smooth 
muscle cells (Zhao et al., 2001; Tang et al., 2005) and insulin secreting cells (Yang et al., 
2005). As such, the opening of KATP channels by H2S could possibly serve as one of the 
downstream effectors of H2S postconditioning 
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4.5.7 Potential mechanisms or effectors of H2S postconditioning 
In addition, H2S was shown to scavenge H2O2 in vitro (Geng et al., 2004), 
protects neuronal cells from oxidative stress partly via increase in glutathione capacity 
(Kimura et al., 2004) and hearts from ischemia injuries (Geng et al., 2004). IPostC was 
shown to protect the heart from ischemia-reperfusion injury partly via inhibiting ROS 
generation (Sun et al., 2005) and oxidant mediated injury (Kin et al., 2004). As such, part 
of the effect may be contributed by the anti-oxidant nature of H2S. Moreover, it was 
recently found that H2S can decrease pHi in vascular smooth muscle cells (Lee et al., 
2007). A recent study showed that IPostC mediates its cardioprotective effects possibly 
via prolonged transient acidosis during the early reperfusion phase with the activation of 
Akt and ERK1/2 (Fujita et al., 2007). Therefore, the acidosis induced by H2S infusion 
might also take part in producing the cardioprotective effect of both IPostC and SPostC.   
 
4.5.8 Conclusion and significance 
 The present study suggests that endogenous H2S plays an important role in 
modulating the cardioprotective effect of IPostC. More importantly, H2S 
postconditioning is able to resume heart contractile functions to a similar extend as those 
produced by IPostC via activation of Akt and PKCε. The effect of H2S postconditioning 
against ischemia-reperfusion injury has provided a firm ground to support H2S as a 
cardioprotective gasotransmitter.  
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5. CONCLUSIONS AND SIGNIFICANCE 
 
The current study attempted to unveil the diverse signaling mechanism of H2S in 
the nervous system and cardiovascular system first at molecular level and later progress 
on to physiological relevance. In the central nervous system, exogenous H2S was found 
to increase [Ca2+]i in primary cultured microglia via Ca2+ influx and Ca2+ release from 
intracellular calcium stores. This effect was dependent on PKA activation. More 
importantly, inhibition of endogenous H2S was found to decrease the basal level of 
[Ca2+]i, suggesting an indispensable intrinsic role for endogenous H2S in the regulation of 
[Ca2+]i under physiological condition and probably the activated state. H2S may play a 
role in neuroinflammation via regulation of Ca2+ homeostasis. 
In the cardiovascular system, the effect of H2S on pHi was first examined. 
Exogenous H2S was found to decrease pHi in vascular smooth muscle cells in a 
concentration-dependent manner. A role for Cl-/HCO3- exchanger on the acidosis induced 
by H2S was discovered. H2S was shown to increase the activity of Cl-/HCO3- exchanger. 
More importantly, the observed acidosis was shown to be partly responsible for the 
vasorelaxation induced by H2S application in aortic rings. Taken together, the current 
study suggests that regulation of vascular tone by H2S may be partly via regulation of pHi.  
The study was further extended to investigate the effect of H2S on activation of 
pro-survival kinase, Akt and PKC. My lab and others have positioned H2S a potent 
cardioprotective agent. The role of endogenous H2S in a cardioprotective phenomenon 
termed ischemic postconditioning which has been shown to be greatly dependent on the 
activation of pro-survival kinases such as ERK, PKC and Akt was examined. In the 
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present experimental setup, the activation of PKC was dependent on endogenous H2S and 
inhibition of H2S diminished the cardioprotective effect of IPostC after ischemia- 
reperfusion injury. More importantly, the potent effect of H2S to induce Akt and PKC 
activation has conferred H2S the position as a candidate for pharmacological 
postconditioning. Postconditioning the heart with H2S produced significant protective 
effect via activation of Akt and PKC. 
To conclude, the current study has reveal three possible signaling mechanisms for 
the action of H2S, namely the [Ca2+]i, pHi and pro-survival kinase, Akt and PKC. The 
data may serve as a pilot study to unveil various undiscovered physiological roles for H2S 
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7.1 Buffering of H+ released from NaHS and H2S  
 
 
Buffering capacity of A7r5 smooth muscle cells upon application of 1 mM NaHS 
 
Smooth muscle cells have a mean βi value of 41 ± 4 mM/pH unit, which is equivalent to a 
value of 310 mM for buffer concentration and a pKa of 6.0 (Austin and Wray 1995). 
 
Assuming the cell as a definite volume of confined compartment, 
 
At pHi = 7.1,  
 
Applying Henderson-Hasselbalch’s equation: 
 
  HA  H+ + A- 
 
   
 
 
   
 
   
 
 
           = 0.0794 
 
∴[HA] : [A-] = 7.356% : 92.644% at equilibrium 
 
 
At 310 mM HA, 
 
[HA] = 310 mM x 7.356% = 22.8036 mM 
[A-] = 310 mM x 92.644% = 287.1946 mM 
 
At 20 ºC, [H+] introduced by 1mM NaHS = 178 µM 
 










As a buffer, to minimize pH change, A- ions will combine with H+ released from H2S 
diffusion to form HA. 
 
[A-]after = [A-]before – [H+]from NaHS 
               = 287.1946 mM – 178 µM 
    = 287018.4 µM 
  
 
[HA]after = [HA]before + [H+]from NaHS 
                 = 22.8036 mM + 178 µM 
                 = 22981.6 µM 
 









 pH = 7.096529 
 
 
Therefore, pHi after application of 1 mM NaHS to vascular smooth muscle cells with a 
buffering capacity of 310 mM at pKa 6.0 would approximate 7.097. 
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